Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:food propellant
go back to main search page
Accession:CHEBI:78017 term browser browse the term
Definition:A propellant that is used to expel foods from an aerosol container.
Synonyms:related_synonym: food propellants



show annotations for term's descendants           Sort by:
 
(-)-secoisolariciresinol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP secoisolariciresinol results in increased activity of NR1I2 protein CTD PMID:15885729 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
JBrowse link
1-nitropropane term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACMSD aminocarboxymuconate semialdehyde decarboxylase increases expression ISO 1-nitropropane results in increased expression of ACMSD mRNA CTD PMID:17070881 NCBI chr 2:134,838,319...134,902,906
Ensembl chr 2:134,838,616...134,902,034
JBrowse link
G ACSL3 acyl-CoA synthetase long chain family member 3 decreases expression ISO 1-nitropropane results in decreased expression of ACSL3 mRNA CTD PMID:17070881 NCBI chr 2:222,861,036...222,944,639
Ensembl chr 2:222,860,942...222,944,639
JBrowse link
G AEN apoptosis enhancing nuclease increases expression ISO 1-nitropropane results in increased expression of AEN mRNA CTD PMID:17070881 NCBI chr15:88,604,601...88,632,281
Ensembl chr15:88,621,337...88,632,281
JBrowse link
G AKR7A3 aldo-keto reductase family 7 member A3 decreases expression ISO 1-nitropropane results in decreased expression of AKR7A3 mRNA CTD PMID:17070881 NCBI chr 1:19,274,229...19,289,362
Ensembl chr 1:19,282,573...19,288,770
JBrowse link
G ALDH1A1 aldehyde dehydrogenase 1 family member A1 increases expression ISO 1-nitropropane results in increased expression of ALDH1A1 mRNA CTD PMID:17070881 NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
JBrowse link
G APOA2 apolipoprotein A2 increases expression ISO 1-nitropropane results in increased expression of APOA2 mRNA CTD PMID:17070881 NCBI chr 1:161,222,292...161,223,628
Ensembl chr 1:161,222,292...161,223,631
JBrowse link
G APOA4 apolipoprotein A4 decreases expression ISO 1-nitropropane results in decreased expression of APOA4 mRNA CTD PMID:17070881 NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
JBrowse link
G APOC3 apolipoprotein C3 increases expression ISO 1-nitropropane results in increased expression of APOC3 mRNA CTD PMID:17070881 NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
JBrowse link
G ATP6V1D ATPase H+ transporting V1 subunit D increases expression ISO 1-nitropropane results in increased expression of ATP6V1D mRNA CTD PMID:17070881 NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265
JBrowse link
G BAX BCL2 associated X, apoptosis regulator increases expression ISO 1-nitropropane results in increased expression of BAX mRNA CTD PMID:17070881 NCBI chr19:48,954,825...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BTG2 BTG anti-proliferation factor 2 decreases expression ISO 1-nitropropane results in decreased expression of BTG2 mRNA CTD PMID:17070881 NCBI chr 1:203,305,519...203,309,602
Ensembl chr 1:203,305,491...203,309,602
JBrowse link
G C7 complement C7 decreases expression ISO 1-nitropropane results in decreased expression of C7 mRNA CTD PMID:17070881 NCBI chr 5:40,909,497...40,984,643
Ensembl chr 5:40,909,497...40,984,643
JBrowse link
G CBLC Cbl proto-oncogene C decreases expression ISO 1-nitropropane results in decreased expression of CBLC mRNA CTD PMID:17070881 NCBI chr19:44,777,855...44,800,652
Ensembl chr19:44,777,869...44,800,652
JBrowse link
G CCNG1 cyclin G1 increases expression ISO 1-nitropropane results in increased expression of CCNG1 mRNA CTD PMID:17070881 NCBI chr 5:163,437,571...163,448,199
Ensembl chr 5:163,437,569...163,446,151
JBrowse link
G CD276 CD276 molecule decreases expression ISO 1-nitropropane results in decreased expression of CD276 mRNA CTD PMID:17070881 NCBI chr15:73,683,966...73,714,518
Ensembl chr15:73,683,966...73,714,514
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A decreases expression ISO 1-nitropropane results in decreased expression of CDKN1A mRNA CTD PMID:17070881 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
JBrowse link
G CPQ carboxypeptidase Q decreases expression ISO 1-nitropropane results in decreased expression of CPQ mRNA CTD PMID:17070881 NCBI chr 8:96,645,242...97,143,501
Ensembl chr 8:96,645,242...97,149,654
JBrowse link
G CRYAB crystallin alpha B decreases expression ISO 1-nitropropane results in decreased expression of CRYAB mRNA CTD PMID:17070881 NCBI chr11:111,908,564...111,923,740
Ensembl chr11:111,908,564...111,923,722
JBrowse link
G DDAH1 dimethylarginine dimethylaminohydrolase 1 decreases expression ISO 1-nitropropane results in decreased expression of DDAH1 mRNA CTD PMID:17070881 NCBI chr 1:85,318,485...85,578,274
Ensembl chr 1:85,318,481...85,578,363
JBrowse link
G EPCAM epithelial cell adhesion molecule decreases expression ISO 1-nitropropane results in decreased expression of EPCAM mRNA CTD PMID:17070881 NCBI chr 2:47,369,311...47,387,020
Ensembl chr 2:47,345,158...47,387,601
JBrowse link
G EPHX1 epoxide hydrolase 1 decreases expression ISO 1-nitropropane results in decreased expression of EPHX1 mRNA CTD PMID:17070881 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
JBrowse link
G FAS Fas cell surface death receptor increases expression ISO 1-nitropropane results in increased expression of FAS mRNA CTD PMID:17070881 NCBI chr10:88,968,429...89,017,059
Ensembl chr10:88,990,531...89,017,059
JBrowse link
G FHIT fragile histidine triad diadenosine triphosphatase increases expression ISO 1-nitropropane results in increased expression of FHIT mRNA CTD PMID:17070881 NCBI chr 3:59,747,277...61,251,452
Ensembl chr 3:59,747,277...61,251,459
JBrowse link
G GRIA3 glutamate ionotropic receptor AMPA type subunit 3 decreases expression ISO 1-nitropropane results in decreased expression of GRIA3 mRNA CTD PMID:17070881 NCBI chr  X:123,184,278...123,490,915
Ensembl chr  X:123,184,153...123,490,915
JBrowse link
G GSTM1 glutathione S-transferase mu 1 decreases expression ISO 1-nitropropane results in decreased expression of GSTM1 mRNA CTD PMID:17070881 NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
JBrowse link
G HSD17B6 hydroxysteroid 17-beta dehydrogenase 6 increases expression ISO 1-nitropropane results in increased expression of HSD17B6 mRNA CTD PMID:17070881 NCBI chr12:56,752,449...56,787,790
Ensembl chr12:56,752,161...56,787,790
JBrowse link
G IL2RA interleukin 2 receptor subunit alpha decreases expression ISO 1-nitropropane results in decreased expression of IL2RA mRNA CTD PMID:17070881 NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
JBrowse link
G MGMT O-6-methylguanine-DNA methyltransferase increases expression ISO 1-nitropropane results in increased expression of MGMT mRNA CTD PMID:17070881 NCBI chr10:129,467,241...129,770,983
Ensembl chr10:129,467,190...129,770,983
JBrowse link
G NUPR1 nuclear protein 1, transcriptional regulator increases expression ISO 1-nitropropane results in increased expression of NUPR1 mRNA CTD PMID:17070881 NCBI chr16:28,532,708...28,538,974
Ensembl chr16:28,532,708...28,539,008
JBrowse link
G PHLDA3 pleckstrin homology like domain family A member 3 decreases expression ISO 1-nitropropane results in decreased expression of PHLDA3 mRNA CTD PMID:17070881 NCBI chr 1:201,464,278...201,469,188
Ensembl chr 1:201,464,278...201,469,237
JBrowse link
G RHOBTB2 Rho related BTB domain containing 2 increases expression ISO 1-nitropropane results in increased expression of RHOBTB2 mRNA CTD PMID:17070881 NCBI chr 8:22,987,251...23,020,199
Ensembl chr 8:22,987,417...23,020,199
JBrowse link
G SERPINA7 serpin family A member 7 decreases expression ISO 1-nitropropane results in decreased expression of SERPINA7 mRNA CTD PMID:17070881 NCBI chr  X:106,032,435...106,038,727
Ensembl chr  X:106,032,435...106,038,727
JBrowse link
G SLC16A10 solute carrier family 16 member 10 increases expression ISO 1-nitropropane results in increased expression of SLC16A10 mRNA CTD PMID:17070881 NCBI chr 6:111,087,503...111,231,194
Ensembl chr 6:111,087,503...111,231,194
JBrowse link
G SPINK1 serine peptidase inhibitor Kazal type 1 increases expression ISO 1-nitropropane results in increased expression of SPINK1 mRNA CTD PMID:17070881 NCBI chr 5:147,824,582...147,839,196
Ensembl chr 5:147,824,572...147,831,671
JBrowse link
G SUGCT succinyl-CoA:glutarate-CoA transferase decreases expression ISO 1-nitropropane results in decreased expression of SUGCT mRNA CTD PMID:17070881 NCBI chr 7:40,134,887...40,860,763
Ensembl chr 7:40,135,005...40,860,763
JBrowse link
G SULF2 sulfatase 2 increases expression ISO 1-nitropropane results in increased expression of SULF2 mRNA CTD PMID:17070881 NCBI chr20:47,657,406...47,786,627
Ensembl chr20:47,656,348...47,786,616
JBrowse link
G SULT2A1 sulfotransferase family 2A member 1 increases expression ISO 1-nitropropane results in increased expression of SULT2A1 mRNA CTD PMID:17070881 NCBI chr19:47,870,467...47,886,315
Ensembl chr19:47,870,467...47,886,315
JBrowse link
G ZMAT3 zinc finger matrin-type 3 decreases expression ISO 1-nitropropane results in decreased expression of ZMAT3 mRNA CTD PMID:17070881 NCBI chr 3:179,017,223...179,072,513
Ensembl chr 3:178,960,121...179,072,215
JBrowse link
aloxistatin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CAPN1 calpain 1 multiple interactions EXP aloxistatin inhibits the reaction [CAPN1 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form] CTD PMID:30910806 NCBI chr11:65,181,373...65,212,006
Ensembl chr11:65,180,566...65,212,006
JBrowse link
G CAPN7 calpain 7 multiple interactions EXP aloxistatin inhibits the reaction [CAPN7 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form] CTD PMID:30910806 NCBI chr 3:15,206,246...15,252,916
Ensembl chr 3:15,206,152...15,252,916
JBrowse link
G CASP3 caspase 3 multiple interactions EXP
ISO
[aloxistatin co-treated with pepstatin] inhibits the reaction [[vistusertib co-treated with Chloroquine] results in increased activity of CASP3 protein]
[Swainsonine co-treated with aloxistatin] results in increased cleavage of CASP3 protein
CTD PMID:26853465 PMID:33186601 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
JBrowse link
G CTSB cathepsin B multiple interactions EXP [aloxistatin co-treated with pepstatin] results in decreased expression of CTSB protein; aloxistatin inhibits the reaction [CTSB protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form] CTD PMID:30910806 PMID:32186374 NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
JBrowse link
G CTSD cathepsin D multiple interactions EXP [aloxistatin co-treated with pepstatin] results in decreased expression of CTSD protein CTD PMID:32186374 NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
JBrowse link
G CTSL cathepsin L multiple interactions EXP aloxistatin inhibits the reaction [CTSL protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form] CTD PMID:30910806 NCBI chr 9:87,726,119...87,731,469
Ensembl chr 9:87,724,051...87,731,469
JBrowse link
G DDX3X DEAD-box helicase 3 X-linked multiple interactions EXP aloxistatin inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of DDX3X protein] CTD PMID:30821613 NCBI chr  X:41,333,308...41,364,472
Ensembl chr  X:41,333,348...41,364,472
JBrowse link
G EIF4A1 eukaryotic translation initiation factor 4A1 multiple interactions EXP aloxistatin inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of EIF4A1 protein] CTD PMID:30821613 NCBI chr17:7,572,825...7,579,006
Ensembl chr17:7,572,824...7,579,006
JBrowse link
G EIF4H eukaryotic translation initiation factor 4H multiple interactions EXP aloxistatin inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of EIF4H protein] CTD PMID:30821613 NCBI chr 7:74,174,356...74,197,096
Ensembl chr 7:74,174,231...74,197,122
JBrowse link
G LAMP2 lysosomal associated membrane protein 2 multiple interactions EXP [aloxistatin co-treated with pepstatin] results in increased expression of LAMP2 protein CTD PMID:32186374 NCBI chr  X:120,426,148...120,469,349
Ensembl chr  X:120,426,148...120,469,365
JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta multiple interactions ISO
EXP
[aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased lipidation of MAP1LC3B protein]
[aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] results in decreased degradation of MAP1LC3B protein modified form
CTD PMID:27635674 NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
JBrowse link
G SMN2 survival of motor neuron 2, centromeric multiple interactions EXP aloxistatin inhibits the reaction [CAPN1 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]; aloxistatin inhibits the reaction [CAPN7 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]; aloxistatin inhibits the reaction [CTSB protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]; aloxistatin inhibits the reaction [CTSL protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form] CTD PMID:30910806 NCBI chr 5:70,049,523...70,077,595
Ensembl chr 5:70,049,638...70,078,522
JBrowse link
G SQSTM1 sequestosome 1 multiple interactions EXP
ISO
[aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein
[aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein; [Dronabinol co-treated with aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein; [HU 211 co-treated with aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein
CTD PMID:32186374 PMID:32773031 NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
JBrowse link
busulfan term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ADRB2 adrenoceptor beta 2 decreases response to substance ISO ADRB2 protein results in decreased susceptibility to Busulfan CTD PMID:7202579 NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
JBrowse link
G ANP32B acidic nuclear phosphoprotein 32 family member B multiple interactions EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of ANP32B protein CTD PMID:20933509 NCBI chr 9:97,983,341...98,015,943
Ensembl chr 9:97,983,341...98,015,943
JBrowse link
G APEX1 apurinic/apyrimidinic endodeoxyribonuclease 1 increases response to substance EXP APEX1 protein mutant form results in increased susceptibility to Busulfan CTD PMID:19470598 NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
JBrowse link
G AR androgen receptor multiple interactions EXP Busulfan inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:18324785 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619
JBrowse link
G ARHGDIA Rho GDP dissociation inhibitor alpha multiple interactions
affects response to substance
EXP ARHGDIA mRNA affects the reaction [Busulfan results in increased activity of CASP3 protein]
ARHGDIA mRNA affects the susceptibility to Busulfan
CTD PMID:17264767 NCBI chr17:81,867,719...81,871,337
Ensembl chr17:81,867,721...81,871,378
JBrowse link
G ATM ATM serine/threonine kinase multiple interactions EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of ATM protein CTD PMID:20933509 NCBI chr11:108,222,484...108,369,102
Ensembl chr11:108,223,044...108,369,102
JBrowse link
G BMP4 bone morphogenetic protein 4 decreases expression ISO Busulfan results in decreased expression of BMP4 mRNA CTD PMID:15786497 NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
JBrowse link
G CASP3 caspase 3 multiple interactions
increases activity
EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP3 protein; [decitabine co-treated with Busulfan] results in increased activity of CASP3 protein; ARHGDIA mRNA affects the reaction [Busulfan results in increased activity of CASP3 protein] CTD PMID:17264767 PMID:18339423 PMID:19732952 PMID:20933509 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
JBrowse link
G CASP8 caspase 8 increases activity
multiple interactions
EXP Busulfan results in increased activity of CASP8 protein
[decitabine co-treated with Busulfan] results in increased activity of CASP8 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP8 protein]
CTD PMID:18339423 PMID:19732952 NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,287,711
JBrowse link
G CASP9 caspase 9 multiple interactions EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP9 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP9 protein] CTD PMID:19732952 PMID:20933509 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CDC25B cell division cycle 25B multiple interactions EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CDC25B protein CTD PMID:20933509 NCBI chr20:3,786,951...3,806,118
Ensembl chr20:3,786,772...3,806,121
JBrowse link
G CDK2 cyclin dependent kinase 2 decreases expression ISO Busulfan results in decreased expression of CDK2 mRNA CTD PMID:15388331 NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
JBrowse link
G CDK4 cyclin dependent kinase 4 decreases expression ISO Busulfan results in decreased expression of CDK4 mRNA CTD PMID:15388331 NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A increases expression
multiple interactions
EXP Busulfan results in increased expression of CDKN1A protein
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased expression of CDKN1A protein
CTD PMID:16882877 PMID:20933509 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A increases expression ISO Busulfan results in increased expression of CDKN2A mRNA CTD PMID:14500376 NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
JBrowse link
G CHEK1 checkpoint kinase 1 multiple interactions EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CHEK1 protein CTD PMID:20933509 NCBI chr11:125,624,910...125,676,255
Ensembl chr11:125,625,163...125,676,255
JBrowse link
G CHEK2 checkpoint kinase 2 multiple interactions EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CHEK2 protein CTD PMID:20933509 NCBI chr22:28,687,743...28,741,866
Ensembl chr22:28,687,743...28,742,422
JBrowse link
G COL4A1 collagen type IV alpha 1 chain affects expression ISO Busulfan affects the expression of COL4A1 mRNA CTD PMID:15941629 NCBI chr13:110,148,963...110,307,157
Ensembl chr13:110,148,963...110,307,157
JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 multiple interactions EXP [GSTM1 protein co-treated with CYP2C9 protein] results in increased susceptibility to [Busulfan co-treated with Cyclophosphamide] CTD PMID:28744217 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
JBrowse link
G FASLG Fas ligand decreases expression ISO Busulfan results in decreased expression of FASL mRNA CTD PMID:15388331 NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
JBrowse link
G FGF8 fibroblast growth factor 8 decreases expression ISO Busulfan results in decreased expression of FGF8 mRNA CTD PMID:15786497 NCBI chr10:101,770,109...101,780,369
Ensembl chr10:101,770,109...101,780,371
JBrowse link
G GDNF glial cell derived neurotrophic factor affects expression
increases expression
ISO Busulfan affects the expression of GDNF mRNA
Busulfan results in increased expression of GDNF mRNA
CTD PMID:20684317 PMID:22082982 PMID:26524245 NCBI chr 5:37,812,677...37,840,044
Ensembl chr 5:37,812,677...37,840,041
JBrowse link
G GPX4 glutathione peroxidase 4 decreases expression
multiple interactions
ISO Busulfan results in decreased expression of GPX4 protein
Busulfan results in decreased expression of and results in decreased activity of GPX4 protein; Deferoxamine inhibits the reaction [Busulfan results in decreased expression of GPX4 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of and results in decreased activity of GPX4 protein]; sulforaphane inhibits the reaction [Busulfan results in decreased expression of and results in decreased activity of GPX4 protein]
CTD PMID:32416107 NCBI chr19:1,103,994...1,106,779
Ensembl chr19:1,103,926...1,106,791
JBrowse link
G GSTA1 glutathione S-transferase alpha 1 multiple interactions
affects response to substance
affects metabolic processing
affects abundance
decreases response to substance
EXP GSTA1 protein affects the metabolism of [Busulfan co-treated with Glutathione]
GSTA1 polymorphism affects the susceptibility to Busulfan
GSTA1 gene polymorphism affects the metabolism of Busulfan; GSTA1 protein affects the metabolism of Busulfan
GSTA1 gene polymorphism affects the abundance of Busulfan
GSTA1 protein results in decreased susceptibility to Busulfan
CTD PMID:8886613 PMID:10437668 PMID:10570028 PMID:12429583 PMID:20672371 More... NCBI chr 6:52,791,371...52,803,827
Ensembl chr 6:52,791,371...52,803,860
JBrowse link
G GSTM1 glutathione S-transferase mu 1 affects metabolic processing
affects response to substance
multiple interactions
affects abundance
EXP GSTM1 protein affects the metabolism of Busulfan
GSTM1 gene polymorphism affects the susceptibility to Busulfan
[GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Busulfan; [GSTM1 protein co-treated with CYP2C9 protein] results in increased susceptibility to [Busulfan co-treated with Cyclophosphamide]
GSTM1 gene polymorphism affects the abundance of Busulfan
CTD PMID:8886613 PMID:15142875 PMID:19584821 PMID:20672371 PMID:21215809 More... NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
JBrowse link
G GSTP1 glutathione S-transferase pi 1 affects metabolic processing
affects abundance
EXP GSTP1 protein affects the metabolism of Busulfan
GSTP1 gene polymorphism affects the abundance of Busulfan
CTD PMID:8886613 PMID:20672371 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
G GSTT1 glutathione S-transferase theta 1 multiple interactions EXP [GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Busulfan CTD PMID:21215809
G H2AX H2A.X variant histone increases phosphorylation
multiple interactions
EXP Busulfan results in increased phosphorylation of H2AX protein
[Clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased expression of H2AX protein
CTD PMID:18339423 PMID:20933509 NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,854...119,095,467
JBrowse link
G INHBA inhibin subunit beta A multiple interactions
increases expression
EXP bisindolylmaleimide I inhibits the reaction [Busulfan results in increased expression of INHBA mRNA]; bisindolylmaleimide I inhibits the reaction [Busulfan results in increased expression of INHBA protein]
Busulfan results in increased expression of INHBA mRNA; Busulfan results in increased expression of INHBA protein
CTD PMID:12966370 PMID:22286157 NCBI chr 7:41,685,101...41,710,532
Ensembl chr 7:41,667,168...41,705,834
JBrowse link
G KIT KIT proto-oncogene, receptor tyrosine kinase decreases expression ISO Busulfan results in decreased expression of KIT mRNA CTD PMID:15388331 NCBI chr 4:54,657,957...54,740,715
Ensembl chr 4:54,657,918...54,740,715
JBrowse link
G LAMA1 laminin subunit alpha 1 affects expression ISO Busulfan affects the expression of LAMA1 mRNA CTD PMID:15941629 NCBI chr18:6,941,742...7,117,797
Ensembl chr18:6,941,742...7,117,797
JBrowse link
G LAMA4 laminin subunit alpha 4 affects expression ISO Busulfan affects the expression of LAMA4 mRNA CTD PMID:15941629 NCBI chr 6:112,107,931...112,254,722
Ensembl chr 6:112,107,931...112,254,939
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 increases activity EXP Busulfan results in increased activity of MAPK1 protein CTD PMID:16882877 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases activity EXP Busulfan results in increased activity of MAPK3 protein CTD PMID:16882877 NCBI chr16:30,114,105...30,123,309
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MGST2 microsomal glutathione S-transferase 2 decreases response to substance EXP MGST2 protein results in decreased susceptibility to Busulfan CTD PMID:15779864 NCBI chr 4:139,665,725...139,754,608
Ensembl chr 4:139,665,768...139,740,745
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor multiple interactions EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in decreased expression of MYC protein CTD PMID:20933509 NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
JBrowse link
G NANOS2 nanos C2HC-type zinc finger 2 decreases expression ISO Busulfan results in decreased expression of NANOS2 mRNA; Busulfan results in decreased expression of NANOS2 protein CTD PMID:26524245 NCBI chr19:45,913,214...45,914,778
Ensembl chr19:45,913,214...45,914,778
JBrowse link
G NANOS3 nanos C2HC-type zinc finger 3 decreases expression ISO Busulfan results in decreased expression of NANOS3 mRNA CTD PMID:26524245 NCBI chr19:13,862,036...13,880,757
Ensembl chr19:13,862,063...13,880,757
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 decreases expression
multiple interactions
ISO Busulfan results in decreased expression of NFE2L2 protein
Deferoxamine inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein]; sulforaphane inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein]
CTD PMID:32416107 NCBI chr 2:177,230,303...177,265,131
Ensembl chr 2:177,227,595...177,392,697
JBrowse link
G NPM1 nucleophosmin 1 multiple interactions EXP NPM1 gene mutant form results in increased susceptibility to [Busulfan co-treated with Idarubicin] CTD PMID:20172040 NCBI chr 5:171,387,116...171,410,900
Ensembl chr 5:171,387,116...171,411,810
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 multiple interactions
increases cleavage
EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of PARP1 protein; [decitabine co-treated with Busulfan] results in increased cleavage of PARP1 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased cleavage of PARP1 protein]
Busulfan results in increased cleavage of PARP1 protein
CTD PMID:18339423 PMID:19732952 PMID:20933509 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
JBrowse link
G PHB prohibitin affects expression ISO Busulfan affects the expression of PHB mRNA CTD PMID:15388331 NCBI chr17:49,404,052...49,414,882
Ensembl chr17:49,404,052...49,414,901
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 increases expression
multiple interactions
EXP
ISO
Busulfan results in increased expression of PTGS2 mRNA
ferrostatin-1 inhibits the reaction [Busulfan results in increased expression of PTGS2 mRNA]
CTD PMID:12966370 PMID:32416107 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G RAD51 RAD51 recombinase decreases expression ISO Busulfan results in decreased expression of RAD51 mRNA CTD PMID:15388331 NCBI chr15:40,694,774...40,732,340
Ensembl chr15:40,694,774...40,732,340
JBrowse link
G RB1 RB transcriptional corepressor 1 decreases phosphorylation ISO Busulfan results in decreased phosphorylation of RB1 protein CTD PMID:15388331 NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
JBrowse link
G SAT2 spermidine/spermine N1-acetyltransferase family member 2 increases expression ISO Busulfan results in increased expression of SAT2 mRNA; Busulfan results in increased expression of SAT2 protein CTD PMID:28578006 NCBI chr17:7,626,234...7,627,878
Ensembl chr17:7,626,234...7,627,876
JBrowse link
G SERPINC1 serpin family C member 1 affects expression EXP Busulfan affects the expression of SERPINC1 protein CTD PMID:15580502 NCBI chr 1:173,903,800...173,917,327
Ensembl chr 1:173,903,800...173,917,327
JBrowse link
G SERPINE1 serpin family E member 1 increases expression
multiple interactions
EXP Busulfan results in increased expression of SERPINE1 mRNA; Busulfan results in increased expression of SERPINE1 protein
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Busulfan results in increased expression of SERPINE1 mRNA]
CTD PMID:22286157 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
JBrowse link
G SLC40A1 solute carrier family 40 member 1 decreases expression
multiple interactions
ISO Busulfan results in decreased expression of SLC40A1 protein
Deferoxamine inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]; sulforaphane inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]
CTD PMID:32416107 NCBI chr 2:189,560,590...189,580,811
Ensembl chr 2:189,560,590...189,583,758
JBrowse link
G SMC1A structural maintenance of chromosomes 1A multiple interactions EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of SMC1A protein CTD PMID:20933509 NCBI chr  X:53,374,149...53,422,728
Ensembl chr  X:53,374,149...53,422,728
JBrowse link
G SMC3 structural maintenance of chromosomes 3 multiple interactions EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of SMC3 protein CTD PMID:20933509 NCBI chr10:110,567,695...110,606,048
Ensembl chr10:110,567,695...110,606,048
JBrowse link
G STRA8 stimulated by retinoic acid 8 decreases expression ISO Busulfan results in decreased expression of STRA8 mRNA CTD PMID:15388331 NCBI chr 7:135,231,915...135,258,663
Ensembl chr 7:135,231,979...135,258,492
JBrowse link
G TF transferrin multiple interactions
increases expression
EXP 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Busulfan results in increased expression of TF mRNA]
Busulfan results in increased expression of TF mRNA; Busulfan results in increased expression of TF protein
CTD PMID:12966370 PMID:22286157 NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
JBrowse link
G TFPI tissue factor pathway inhibitor decreases expression EXP Busulfan results in decreased expression of TFPI mRNA CTD PMID:22286157 NCBI chr 2:187,464,230...187,554,501
Ensembl chr 2:187,464,230...187,565,760
JBrowse link
G TFRC transferrin receptor decreases expression
multiple interactions
ISO Busulfan results in decreased expression of TFRC protein
Deferoxamine promotes the reaction [Busulfan results in decreased expression of TFRC protein]
CTD PMID:32416107 NCBI chr 3:196,018,694...196,082,123
Ensembl chr 3:196,027,183...196,082,096
JBrowse link
G TGFB1 transforming growth factor beta 1 increases expression EXP Busulfan results in increased expression of TGFB1 mRNA CTD PMID:22286157 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
G THBS1 thrombospondin 1 increases expression EXP Busulfan results in increased expression of THBS1 mRNA CTD PMID:22286157 NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
JBrowse link
G TNF tumor necrosis factor increases expression EXP Busulfan results in increased expression of TNF mRNA CTD PMID:22286157 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TP53 tumor protein p53 multiple interactions EXP Busulfan affects the phosphorylation of and affects the activity of TP53 protein CTD PMID:16882877 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TXNRD1 thioredoxin reductase 1 decreases activity ISO Busulfan results in decreased activity of TXNRD1 protein CTD PMID:16085187 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
JBrowse link
G XIAP X-linked inhibitor of apoptosis multiple interactions EXP [clofarabine co-treated with fludarabine co-treated with Busulfan] results in decreased expression of XIAP protein CTD PMID:20933509 NCBI chr  X:123,859,708...123,913,972
Ensembl chr  X:123,859,724...123,913,976
JBrowse link
G ZBTB16 zinc finger and BTB domain containing 16 increases expression ISO Busulfan results in increased expression of ZBTB16 mRNA CTD PMID:26524245 NCBI chr11:114,059,576...114,256,770
Ensembl chr11:114,059,041...114,256,765
JBrowse link
butan-2-ol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CHRNA2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions EXP 2-butanol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]] CTD PMID:11821649 NCBI chr 8:27,459,756...27,479,285
Ensembl chr 8:27,459,756...27,479,883
JBrowse link
G CHRNB4 cholinergic receptor nicotinic beta 4 subunit multiple interactions EXP 2-butanol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]] CTD PMID:11821649 NCBI chr15:78,623,282...78,655,586
Ensembl chr15:78,624,111...78,727,754
JBrowse link
G EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions ISO 2-butanol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of EIF4EBP1 protein] CTD PMID:14769825 NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
JBrowse link
G GH1 growth hormone 1 affects folding EXP 2-butanol affects the folding of GH1 protein CTD PMID:11064379 NCBI chr17:63,917,203...63,918,839
Ensembl chr17:63,917,200...63,918,839
JBrowse link
butane term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BAX BCL2 associated X, apoptosis regulator increases expression EXP butane results in increased expression of BAX mRNA CTD PMID:33064461 NCBI chr19:48,954,825...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G FN1 fibronectin 1 decreases expression EXP butane results in decreased expression of FN1 mRNA CTD PMID:33064461 NCBI chr 2:215,360,862...215,436,167
Ensembl chr 2:215,360,440...215,436,073
JBrowse link
butane-1,3-diol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 increases activity
increases expression
ISO 1,3-butylene glycol results in increased activity of CYP2E1 protein
1,3-butylene glycol results in increased expression of CYP2E1 protein
CTD PMID:2919394 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
JBrowse link
butane-2,3-diol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AKR1B1 aldo-keto reductase family 1 member B multiple interactions EXP [AKR1B1 protein results in increased reduction of Acetoin] which results in increased chemical synthesis of 2,3-butylene glycol CTD PMID:23295224 NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
JBrowse link
G AKR1B10 aldo-keto reductase family 1 member B10 multiple interactions EXP [AKR1B10 protein results in increased reduction of Acetoin] which results in increased chemical synthesis of 2,3-butylene glycol CTD PMID:23295224 NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
JBrowse link
G ALDH2 aldehyde dehydrogenase 2 family member increases metabolic processing EXP ALDH2 protein results in increased metabolism of 2,3-butylene glycol CTD PMID:10064379 NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
JBrowse link
carbon dioxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BDNF brain derived neurotrophic factor multiple interactions ISO [Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein] CTD PMID:24718106 NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
JBrowse link
G CALCA calcitonin related polypeptide alpha multiple interactions
increases secretion
ISO Carbon Dioxide inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; Carbon Dioxide inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]; Carbon Dioxide inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased secretion of CALCA protein]
Carbon Dioxide results in increased secretion of CALCA protein
CTD PMID:18052948 NCBI chr11:14,966,668...14,972,361
Ensembl chr11:14,966,668...14,972,351
JBrowse link
G CAMK2B calcium/calmodulin dependent protein kinase II beta multiple interactions ISO [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein] CTD PMID:24718106 NCBI chr 7:44,217,154...44,326,167
Ensembl chr 7:44,217,150...44,334,577
JBrowse link
G CREB1 cAMP responsive element binding protein 1 multiple interactions ISO [Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein] CTD PMID:24718106 NCBI chr 2:207,529,943...207,605,988
Ensembl chr 2:207,529,737...207,605,988
JBrowse link
G CRH corticotropin releasing hormone increases response to substance EXP CRH protein results in increased susceptibility to Carbon Dioxide CTD PMID:8957205 NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
JBrowse link
G DLG3 discs large MAGUK scaffold protein 3 multiple interactions ISO [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein] CTD PMID:24718106 NCBI chr  X:70,444,835...70,505,490
Ensembl chr  X:70,444,835...70,505,490
JBrowse link
G GRIN2B glutamate ionotropic receptor NMDA type subunit 2B multiple interactions ISO [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein] CTD PMID:24718106 NCBI chr12:13,537,337...13,982,012
Ensembl chr12:13,437,942...13,982,002
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions ISO [Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK1 mRNA; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK1 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK1 mRNA]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK1 protein] CTD PMID:24718106 PMID:25004876 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions ISO [Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK3 mRNA; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK3 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK3 mRNA]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK3 protein] CTD PMID:24718106 PMID:25004876 NCBI chr16:30,114,105...30,123,309
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G NEIL1 nei like DNA glycosylase 1 affects abundance ISO NEIL1 affects the abundance of Carbon Dioxide CTD PMID:21285402 NCBI chr15:75,346,638...75,357,115
Ensembl chr15:75,346,955...75,357,115
JBrowse link
G NGB neuroglobin affects binding ISO Carbon Dioxide binds to [Heme binds to NGB protein] CTD PMID:16684569 NCBI chr14:77,265,483...77,271,206
Ensembl chr14:77,265,483...77,271,206
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha multiple interactions ISO PPARA protein promotes the reaction [[GW 7647 results in increased oxidation of Palmitic Acid] which results in increased abundance of Carbon Dioxide] CTD PMID:21324916 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,756
JBrowse link
G RAPGEF3 Rap guanine nucleotide exchange factor 3 multiple interactions ISO [RAPGEF3 protein affects the susceptibility to Dietary Fats] which affects the chemical synthesis of Carbon Dioxide CTD PMID:27381457 NCBI chr12:47,734,363...47,758,880
Ensembl chr12:47,734,363...47,771,040
JBrowse link
G SLC9A1 solute carrier family 9 member A1 affects response to substance ISO SLC9A1 protein affects the susceptibility to Carbon Dioxide CTD PMID:16831598 NCBI chr 1:27,098,809...27,155,125
Ensembl chr 1:27,098,809...27,166,981
JBrowse link
G SOD1 superoxide dismutase 1 multiple interactions EXP [[[Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein binds to peroxycarbonic acid]] which results in increased reduction of peroxycarbonic acid] which results in increased chemical synthesis of Carbonates; [[Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein binds to peroxycarbonic acid]] which results in increased reduction of peroxycarbonic acid; [[SOD1 protein results in increased metabolism of Hydrogen Peroxide] results in increased oxidation of [Bicarbonates co-treated with Carbon Dioxide]] which results in increased chemical synthesis of Carbonates; [Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein binds to peroxycarbonic acid]; [Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein results in increased metabolism of Hydrogen Peroxide]; [SOD1 protein results in increased metabolism of Hydrogen Peroxide] results in increased oxidation of [Bicarbonates co-treated with Carbon Dioxide] CTD PMID:19243126 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
JBrowse link
G SYNGAP1 synaptic Ras GTPase activating protein 1 multiple interactions ISO [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of SYNGAP1 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of SYNGAP1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of SYNGAP1 protein] CTD PMID:24718106 NCBI chr 6:33,420,065...33,453,689
Ensembl chr 6:33,419,661...33,453,689
JBrowse link
G TPI1 triosephosphate isomerase 1 increases expression ISO Carbon Dioxide results in increased expression of TPI1 mRNA CTD PMID:14762718 NCBI chr12:6,866,834...6,870,948
Ensembl chr12:6,867,119...6,870,948
JBrowse link
G TRH thyrotropin releasing hormone increases response to substance EXP TRH protein results in increased susceptibility to Carbon Dioxide CTD PMID:8957205 NCBI chr 3:129,974,720...129,977,935
Ensembl chr 3:129,974,688...129,977,935
JBrowse link
G TRPA1 transient receptor potential cation channel subfamily A member 1 increases activity ISO Carbon Dioxide results in increased activity of TRPA1 protein CTD PMID:20881114 NCBI chr 8:72,021,250...72,094,885
Ensembl chr 8:72,019,917...72,075,584
JBrowse link
G TRPV1 transient receptor potential cation channel subfamily V member 1 affects response to substance ISO TRPV1 protein affects the susceptibility to Carbon Dioxide CTD PMID:16831598 NCBI chr17:3,565,446...3,609,411
Ensembl chr17:3,565,444...3,609,411
JBrowse link
DAPT term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACTA2 actin alpha 2, smooth muscle multiple interactions EXP 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one promotes the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]] CTD PMID:31348943 NCBI chr10:88,935,074...88,991,397
Ensembl chr10:88,935,074...88,991,339
JBrowse link
G AKT1 AKT serine/threonine kinase 1 multiple interactions EXP 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one promotes the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of AKT1 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of AKT1 protein] CTD PMID:31348943 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G APP amyloid beta precursor protein multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased secretion of APP protein modified form] CTD PMID:22115781 NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,550...26,171,128
JBrowse link
G BAX BCL2 associated X, apoptosis regulator increases expression ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of BAX protein CTD PMID:21209419 NCBI chr19:48,954,825...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BCL2 BCL2 apoptosis regulator decreases expression ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of BCL2 protein CTD PMID:21209419 NCBI chr18:63,123,346...63,320,280
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BMP6 bone morphogenetic protein 6 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT10 mRNA] CTD PMID:23566955 NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728
JBrowse link
G CASP3 caspase 3 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of and results in increased activity of CASP3 protein CTD PMID:21209419 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
JBrowse link
G CCND1 cyclin D1 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of CCND1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of CCND1 mRNA] CTD PMID:19160421 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CDH1 cadherin 1 multiple interactions EXP [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester co-treated with 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one] inhibits the reaction [polyhexamethyleneguanidine results in decreased expression of CDH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased secretion of CDH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium results in increased cleavage of CDH1 protein] CTD PMID:18791180 PMID:31348943 NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
JBrowse link
G CDH2 cadherin 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of CDH2 protein] CTD PMID:23876460 NCBI chr18:27,932,878...28,177,130
Ensembl chr18:27,932,879...28,177,946
JBrowse link
G CSF1 colony stimulating factor 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of CSF1 mRNA] CTD PMID:24223152 NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
JBrowse link
G ENO2 enolase 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of ENO2 mRNA] CTD PMID:24929042 NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
JBrowse link
G FLT1 fms related receptor tyrosine kinase 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of FLT1 protein] CTD PMID:21843347 NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
JBrowse link
G FOXO3 forkhead box O3 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Hydrogen Peroxide results in increased expression of FOXO3 protein] CTD PMID:25108166 NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
JBrowse link
G HES1 hes family bHLH transcription factor 1 multiple interactions
decreases expression
EXP
ISO
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Hydrogen Peroxide results in increased expression of HES1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of HES1 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of HES1 mRNA]
CTD PMID:19160421 PMID:24223152 PMID:25005833 PMID:25108166 PMID:32041402 NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
JBrowse link
G HEY1 hes related family bHLH transcription factor with YRPW motif 1 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY1 mRNA] CTD PMID:19160421 NCBI chr 8:79,764,010...79,767,767
Ensembl chr 8:79,762,371...79,767,857
JBrowse link
G HEY2 hes related family bHLH transcription factor with YRPW motif 2 multiple interactions EXP
ISO
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY2 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY2 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Niclosamide results in increased expression of HEY2 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of HEY2 mRNA]
CTD PMID:19160421 PMID:32041402 NCBI chr 6:125,747,639...125,762,243
Ensembl chr 6:125,747,664...125,761,269
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Hydrogen Peroxide results in increased expression of HIF1A protein] CTD PMID:25108166 NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
JBrowse link
G HMGB1 high mobility group box 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of HMGB1 protein] CTD PMID:21843347 NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
JBrowse link
G IL10 interleukin 10 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA] CTD PMID:24223152 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL1B interleukin 1 beta multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]
CTD PMID:21843347 PMID:24223152 NCBI chr 2:112,829,751...112,836,843
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL6 interleukin 6 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]
CTD PMID:21843347 PMID:24223152 NCBI chr 7:22,725,889...22,732,002
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G ITGAM integrin subunit alpha M multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of ITGAM protein] CTD PMID:28130038 NCBI chr16:31,259,975...31,332,877
Ensembl chr16:31,259,967...31,332,892
JBrowse link
G IVL involucrin decreases expression EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL protein CTD PMID:18633435 NCBI chr 1:152,908,546...152,911,886
Ensembl chr 1:152,908,546...152,911,886
JBrowse link
G JAG1 jagged canonical Notch ligand 1 decreases expression EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 protein CTD PMID:18633435 NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
JBrowse link
G KRT1 keratin 1 multiple interactions
decreases expression
EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [U 0126 results in increased expression of KRT1 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT1 mRNA
CTD PMID:18633435 PMID:23566955 NCBI chr12:52,674,736...52,680,407
Ensembl chr12:52,674,736...52,680,407
JBrowse link
G KRT10 keratin 10 multiple interactions
decreases expression
EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT10 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [U 0126 results in increased expression of KRT10 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT10 mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT10 protein
CTD PMID:18633435 PMID:23566955 NCBI chr17:40,818,117...40,822,614
Ensembl chr17:40,818,117...40,822,614
JBrowse link
G LGR5 leucine rich repeat containing G protein-coupled receptor 5 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of LGR5 mRNA] CTD PMID:32041402 NCBI chr12:71,439,798...71,586,310
Ensembl chr12:71,439,798...71,586,310
JBrowse link
G MAP2 microtubule associated protein 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of MAP2 mRNA] CTD PMID:24929042 NCBI chr 2:209,424,047...209,734,118
Ensembl chr 2:209,424,047...209,734,118
JBrowse link
G MDM2 MDM2 proto-oncogene multiple interactions
increases expression
EXP Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of MDM2 protein] CTD PMID:25005833 NCBI chr12:68,808,149...68,850,686
Ensembl chr12:68,808,177...68,845,544
JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA]
CTD PMID:24223152 NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,478...38,143,022
JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 mRNA]
CTD PMID:24223152 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
JBrowse link
G NOTCH1 notch receptor 1 multiple interactions
decreases expression
EXP
ISO
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Hydrogen Peroxide results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [phenethyl isothiocyanate results in increased cleavage of and results in increased activity of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [polyhexamethyleneguanidine results in increased cleavage of NOTCH1 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased cleavage of and results in decreased activity of NOTCH1 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency affects the localization of NOTCH1 protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Oxygen deficiency results in increased expression of NOTCH1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH1 protein modified form
CTD PMID:18633435 PMID:22039516 PMID:22115781 PMID:24223152 PMID:25108166 More... NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
JBrowse link
G NOTCH2 notch receptor 2 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased cleavage of and results in decreased activity of NOTCH2 protein CTD PMID:22039516 NCBI chr 1:119,911,553...120,069,662
Ensembl chr 1:119,911,553...120,100,779
JBrowse link
G NUMB NUMB endocytic adaptor protein increases expression EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of NUMB protein CTD PMID:25005833 NCBI chr14:73,275,216...73,458,546
Ensembl chr14:73,275,107...73,458,617
JBrowse link
G PML PML nuclear body scaffold multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]] CTD PMID:28130038 NCBI chr15:73,994,716...74,047,827
Ensembl chr15:73,994,673...74,047,827
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium results in increased expression of PTGS2 mRNA] CTD PMID:18791180 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G RARA retinoic acid receptor alpha multiple interactions EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]] CTD PMID:28130038 NCBI chr17:40,309,180...40,357,643
Ensembl chr17:40,309,180...40,357,643
JBrowse link
G RBPJ recombination signal binding protein for immunoglobulin kappa J region multiple interactions
increases expression
ISO
EXP
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of RBPJ mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of RBPJ protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cycloheximide results in decreased expression of RBPJ protein]
CTD PMID:22302987 PMID:24223152 NCBI chr 4:26,163,458...26,435,131
Ensembl chr 4:26,163,455...26,435,131
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency affects the localization of RELA protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of RELA protein] CTD PMID:24223152 NCBI chr11:65,653,601...65,662,946
Ensembl chr11:65,653,597...65,663,090
JBrowse link
G TGFB1 transforming growth factor beta 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TGFB1 mRNA] CTD PMID:24223152 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
G TLR4 toll like receptor 4 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TLR4 mRNA] CTD PMID:24223152 NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
JBrowse link
G TNF tumor necrosis factor multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TNF protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TNF mRNA]
CTD PMID:24223152 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TP53 tumor protein p53 decreases expression
multiple interactions
EXP N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein
Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein]
CTD PMID:25005833 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TRAF6 TNF receptor associated factor 6 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TRAF6 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TRAF6 mRNA]
CTD PMID:24223152 NCBI chr11:36,483,769...36,510,313
Ensembl chr11:36,483,769...36,510,272
JBrowse link
G TUBB3 tubulin beta 3 class III multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of TUBB3 mRNA] CTD PMID:24929042 NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
JBrowse link
G VEGFA vascular endothelial growth factor A multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of VEGFA protein] CTD PMID:21843347 NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G VIL1 villin 1 multiple interactions ISO N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of VIL1 mRNA] CTD PMID:32041402 NCBI chr 2:218,419,123...218,453,295
Ensembl chr 2:218,419,121...218,453,295
JBrowse link
diisobutyl phthalate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A4GALT alpha 1,4-galactosyltransferase (P blood group) multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of A4GALT mRNA CTD PMID:31199487 NCBI chr22:42,692,115...42,721,301
Ensembl chr22:42,692,121...42,721,298
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group) multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ABCG2 mRNA CTD PMID:31199487 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
JBrowse link
G ADAMTS1 ADAM metallopeptidase with thrombospondin type 1 motif 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of ADAMTS1 mRNA] CTD PMID:33316053 NCBI chr21:26,835,755...26,845,409
Ensembl chr21:26,835,755...26,845,409
JBrowse link
G AK5 adenylate kinase 5 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of AK5 mRNA CTD PMID:31199487 NCBI chr 1:77,281,908...77,559,966
Ensembl chr 1:77,282,019...77,559,966
JBrowse link
G ALDH1A1 aldehyde dehydrogenase 1 family member A1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDH1A1 mRNA CTD PMID:30768133 NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
JBrowse link
G ALDH2 aldehyde dehydrogenase 2 family member decreases expression ISO diisobutyl phthalate results in decreased expression of ALDH2 mRNA CTD PMID:33983380 NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
JBrowse link
G ALDOC aldolase, fructose-bisphosphate C multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA CTD PMID:31199487 NCBI chr17:28,573,115...28,576,963
Ensembl chr17:28,573,115...28,576,948
JBrowse link
G AMHR2 anti-Mullerian hormone receptor type 2 increases expression ISO diisobutyl phthalate results in increased expression of AMHR2 mRNA CTD PMID:22112501 NCBI chr12:53,423,855...53,431,672
Ensembl chr12:53,423,855...53,431,672
JBrowse link
G AR androgen receptor affects binding
multiple interactions
ISO
EXP
diisobutyl phthalate binds to AR protein
diisobutyl phthalate inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; diisobutyl phthalate inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]
CTD PMID:14565775 PMID:15840436 PMID:28571686 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619
JBrowse link
G ARNT2 aryl hydrocarbon receptor nuclear translocator 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ARNT2 mRNA CTD PMID:31199487 NCBI chr15:80,404,382...80,597,933
Ensembl chr15:80,404,350...80,597,933
JBrowse link
G ASTN1 astrotactin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN1 mRNA CTD PMID:31199487 NCBI chr 1:176,855,117...177,164,854
Ensembl chr 1:176,857,302...177,164,973
JBrowse link
G ASTN2 astrotactin 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN2 mRNA CTD PMID:31199487 NCBI chr 9:116,423,112...117,415,057
Ensembl chr 9:116,423,112...117,415,070
JBrowse link
G ATP1A3 ATPase Na+/K+ transporting subunit alpha 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ATP1A3 mRNA CTD PMID:31199487 NCBI chr19:41,966,582...41,994,230
Ensembl chr19:41,966,582...41,997,497
JBrowse link
G BAX BCL2 associated X, apoptosis regulator multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BAX mRNA CTD PMID:28013214 NCBI chr19:48,954,825...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BCAT1 branched chain amino acid transaminase 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BCAT1 mRNA CTD PMID:31199487 NCBI chr12:24,810,024...24,949,101
Ensembl chr12:24,810,024...24,949,101
JBrowse link
G BCL2 BCL2 apoptosis regulator multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA CTD PMID:28013214 NCBI chr18:63,123,346...63,320,280
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BEND6 BEN domain containing 6 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BEND6 mRNA CTD PMID:31199487 NCBI chr 6:56,954,981...57,027,652
Ensembl chr 6:56,955,107...57,027,346
JBrowse link
G BPGM bisphosphoglycerate mutase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BPGM mRNA CTD PMID:31199487 NCBI chr 7:134,646,853...134,679,816
Ensembl chr 7:134,646,811...134,679,816
JBrowse link
G CACNG7 calcium voltage-gated channel auxiliary subunit gamma 7 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CACNG7 mRNA CTD PMID:31199487 NCBI chr19:53,909,278...53,943,950
Ensembl chr19:53,909,278...53,943,950
JBrowse link
G CADM3 cell adhesion molecule 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CADM3 mRNA CTD PMID:31199487 NCBI chr 1:159,171,592...159,203,313
Ensembl chr 1:159,171,609...159,203,313
JBrowse link
G CADPS calcium dependent secretion activator multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CADPS mRNA CTD PMID:31199487 NCBI chr 3:62,398,348...62,875,865
Ensembl chr 3:62,398,346...62,875,416
JBrowse link
G CAMK4 calcium/calmodulin dependent protein kinase IV multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CAMK4 mRNA CTD PMID:31199487 NCBI chr 5:111,223,583...111,498,503
Ensembl chr 5:111,223,653...111,494,886
JBrowse link
G CASP8 caspase 8 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CASP8 mRNA CTD PMID:28013214 NCBI chr 2:201,233,443...201,287,711
Ensembl chr 2:201,233,443...201,287,711
JBrowse link
G CAT catalase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CAT mRNA CTD PMID:28013214 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CCND2 cyclin D2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CCND2 mRNA CTD PMID:28013214 NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA] CTD PMID:33316053 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
JBrowse link
G CDKN2A cyclin dependent kinase inhibitor 2A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CDKN2A mRNA CTD PMID:28013214 NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
JBrowse link
G CELSR3 cadherin EGF LAG seven-pass G-type receptor 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CELSR3 mRNA CTD PMID:31199487 NCBI chr 3:48,636,463...48,662,886
Ensembl chr 3:48,636,463...48,662,886
JBrowse link
G CGA glycoprotein hormones, alpha polypeptide multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of EDN2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of MMP9 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PGR mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PLAT mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of IL6 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PTGS2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINB2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINE1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of TIMP1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP14 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP16 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of SLCO2A1 mRNA] CTD PMID:33316053 NCBI chr 6:87,085,498...87,095,106
Ensembl chr 6:87,085,498...87,095,106
JBrowse link
G CHGA chromogranin A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CHGA mRNA CTD PMID:31199487 NCBI chr14:92,922,594...92,935,293
Ensembl chr14:92,923,150...92,935,285
JBrowse link
G CHGB chromogranin B multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CHGB mRNA CTD PMID:31199487 NCBI chr20:5,911,510...5,925,353
Ensembl chr20:5,911,510...5,925,353
JBrowse link
G CITED1 Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CITED1 mRNA CTD PMID:31199487 NCBI chr  X:72,301,646...72,307,157
Ensembl chr  X:72,301,638...72,307,187
JBrowse link
G CLSTN3 calsyntenin 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CLSTN3 mRNA CTD PMID:31199487 NCBI chr12:7,130,371...7,158,945
Ensembl chr12:7,129,698...7,158,945
JBrowse link
G CNTNAP1 contactin associated protein 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CNTNAP1 mRNA CTD PMID:31199487 NCBI chr17:42,679,767...42,699,993
Ensembl chr17:42,682,531...42,699,993
JBrowse link
G CRMP1 collapsin response mediator protein 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CRMP1 mRNA CTD PMID:31199487 NCBI chr 4:5,820,764...5,893,086
Ensembl chr 4:5,748,084...5,893,086
JBrowse link
G CYP11A1 cytochrome P450 family 11 subfamily A member 1 decreases expression
multiple interactions
ISO diisobutyl phthalate results in decreased expression of CYP11A1 mRNA; diisobutyl phthalate results in decreased expression of CYP11A1 protein
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11A1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP11A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA
CTD PMID:16458459 PMID:21633115 PMID:22112501 PMID:28013214 PMID:30802670 More... NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
JBrowse link
G CYP11B2 cytochrome P450 family 11 subfamily B member 2 multiple interactions
decreases expression
ISO [diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11B2 mRNA
diisobutyl phthalate results in decreased expression of CYP11B2 mRNA
CTD PMID:33983380 NCBI chr 8:142,910,559...142,917,843
Ensembl chr 8:142,910,559...142,917,843
JBrowse link
G CYP17A1 cytochrome P450 family 17 subfamily A member 1 decreases expression
multiple interactions
ISO diisobutyl phthalate results in decreased expression of CYP17A1 mRNA
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP17A1 mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA
CTD PMID:22112501 PMID:28655647 PMID:30802670 PMID:33983380 NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
JBrowse link
G CYP19A1 cytochrome P450 family 19 subfamily A member 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP19A1 mRNA CTD PMID:28013214 NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
JBrowse link
G CYP51A1 cytochrome P450 family 51 subfamily A member 1 decreases expression ISO diisobutyl phthalate results in decreased expression of CYP51 mRNA CTD PMID:33983380 NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,112,153...92,134,803
JBrowse link
G DCLK3 doublecortin like kinase 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DCLK3 mRNA CTD PMID:31199487 NCBI chr 3:36,712,421...36,764,553
Ensembl chr 3:36,712,422...36,764,349
JBrowse link
G DDC dopa decarboxylase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DDC mRNA CTD PMID:31199487 NCBI chr 7:50,458,436...50,565,460
Ensembl chr 7:50,458,436...50,565,405
JBrowse link
G DHCR7 7-dehydrocholesterol reductase multiple interactions
decreases expression
ISO [diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of DHCR7 mRNA
diisobutyl phthalate results in decreased expression of DHCR7 mRNA
CTD PMID:33983380 NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868
JBrowse link
G DOCK3 dedicator of cytokinesis 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DOCK3 mRNA CTD PMID:31199487 NCBI chr 3:50,674,927...51,384,198
Ensembl chr 3:50,674,927...51,384,198
JBrowse link
G DPF1 double PHD fingers 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DPF1 mRNA CTD PMID:31199487 NCBI chr19:38,211,006...38,229,695
Ensembl chr19:38,211,006...38,229,714
JBrowse link
G DYNC1I1 dynein cytoplasmic 1 intermediate chain 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DYNC1I1 mRNA CTD PMID:31199487 NCBI chr 7:95,772,554...96,110,322
Ensembl chr 7:95,772,506...96,110,322
JBrowse link
G EBP EBP cholestenol delta-isomerase decreases expression ISO diisobutyl phthalate results in decreased expression of EBP mRNA CTD PMID:33983380 NCBI chr  X:48,521,808...48,528,716
Ensembl chr  X:48,521,799...48,528,716
JBrowse link
G ECE2 endothelin converting enzyme 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ECE2 mRNA CTD PMID:31199487 NCBI chr 3:184,276,022...184,293,031
Ensembl chr 3:184,276,011...184,293,031
JBrowse link
G EDN1 endothelin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EDN1 mRNA CTD PMID:31199487 NCBI chr 6:12,256,463...12,297,194
Ensembl chr 6:12,290,361...12,297,194
JBrowse link
G EDN2 endothelin 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of EDN2 mRNA] CTD PMID:33316053 NCBI chr 1:41,478,775...41,484,699
Ensembl chr 1:41,478,775...41,484,683
JBrowse link
G ELMOD1 ELMO domain containing 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ELMOD1 mRNA CTD PMID:31199487 NCBI chr11:107,591,009...107,666,779
Ensembl chr11:107,591,091...107,666,779
JBrowse link
G EMX2 empty spiracles homeobox 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EMX2 mRNA CTD PMID:31199487 NCBI chr10:117,542,746...117,549,546
Ensembl chr10:117,542,445...117,549,546
JBrowse link
G EPDR1 ependymin related 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EPDR1 mRNA CTD PMID:31199487 NCBI chr 7:37,920,640...37,951,936
Ensembl chr 7:37,683,843...37,951,936
JBrowse link
G ESPN espin multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ESPN mRNA CTD PMID:31199487 NCBI chr 1:6,424,776...6,461,367
Ensembl chr 1:6,424,776...6,461,367
JBrowse link
G ESR1 estrogen receptor 1 multiple interactions
increases activity
EXP
ISO
diisobutyl phthalate binds to and results in increased activity of ESR1 protein; diisobutyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR1 protein]; Tamoxifen inhibits the reaction [diisobutyl phthalate binds to and results in increased activity of ESR1 protein]
diisobutyl phthalate results in increased activity of ESR1 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ESR1 mRNA
CTD PMID:15840436 PMID:27633901 PMID:28013214 PMID:28571686 NCBI chr 6:151,654,148...152,129,619
Ensembl chr 6:151,656,691...152,129,619
JBrowse link
G ESR2 estrogen receptor 2 multiple interactions
increases activity
EXP diisobutyl phthalate binds to and results in increased activity of ESR2 protein; diisobutyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR2 protein]
diisobutyl phthalate results in increased activity of ESR2 protein
CTD PMID:27633901 PMID:28571686 NCBI chr14:64,226,707...64,338,631
Ensembl chr14:64,084,232...64,338,112
JBrowse link
G FABP5 fatty acid binding protein 5 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA CTD PMID:31199487 NCBI chr 8:81,280,536...81,284,775
Ensembl chr 8:81,280,536...81,284,777
JBrowse link
G FAM163A family with sequence similarity 163 member A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FAM163A mRNA CTD PMID:31199487 NCBI chr 1:179,727,763...179,816,198
Ensembl chr 1:179,743,163...179,816,198
JBrowse link
G FDPS farnesyl diphosphate synthase decreases expression ISO diisobutyl phthalate results in decreased expression of FDPS mRNA CTD PMID:33983380 NCBI chr 1:155,308,801...155,320,665
Ensembl chr 1:155,308,748...155,320,666
JBrowse link
G FEZ1 fasciculation and elongation protein zeta 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FEZ1 mRNA CTD PMID:31199487 NCBI chr11:125,442,881...125,496,265
Ensembl chr11:125,442,881...125,592,568
JBrowse link
G FKBP1B FKBP prolyl isomerase 1B multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FKBP1B mRNA CTD PMID:31199487 NCBI chr 2:24,033,205...24,067,743
Ensembl chr 2:24,049,701...24,063,681
JBrowse link
G FLG filaggrin multiple interactions EXP [FLG gene polymorphism affects the susceptibility to diisobutyl phthalate] which affects the abundance of mono-isobutyl phthalate CTD PMID:24380925 NCBI chr 1:152,302,165...152,325,239
Ensembl chr 1:152,302,165...152,325,239
JBrowse link
G FSHR follicle stimulating hormone receptor multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FSHR mRNA CTD PMID:28013214 NCBI chr 2:48,953,161...49,154,527
Ensembl chr 2:48,962,157...49,154,527
JBrowse link
G FXYD7 FXYD domain containing ion transport regulator 7 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FXYD7 mRNA CTD PMID:31199487 NCBI chr19:35,143,255...35,154,302
Ensembl chr19:35,143,250...35,154,302
JBrowse link
G GFRA3 GDNF family receptor alpha 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GFRA3 mRNA CTD PMID:31199487 NCBI chr 5:138,252,380...138,274,621
Ensembl chr 5:138,252,380...138,274,621
JBrowse link
G GFRA4 GDNF family receptor alpha 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GFRA4 mRNA CTD PMID:31199487 NCBI chr20:3,659,248...3,663,399
Ensembl chr20:3,659,248...3,663,399
JBrowse link
G GGTA1 glycoprotein alpha-galactosyltransferase 1 (inactive) multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GGTA1 mRNA CTD PMID:31199487 NCBI chr 9:121,444,990...121,499,844
Ensembl chr 9:121,444,991...121,499,844
JBrowse link
G GNG2 G protein subunit gamma 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GNG2 mRNA CTD PMID:31199487 NCBI chr14:51,826,174...51,969,800
Ensembl chr14:51,826,195...51,979,342
JBrowse link
G GPX1 glutathione peroxidase 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GPX1 mRNA CTD PMID:28013214 NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,176...49,358,353
JBrowse link
G GSR glutathione-disulfide reductase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GSR mRNA CTD PMID:28013214 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G GSTA1 glutathione S-transferase alpha 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GSTA3 mRNA CTD PMID:31199487 NCBI chr 6:52,791,371...52,803,827
Ensembl chr 6:52,791,371...52,803,860
JBrowse link
G HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase decreases expression ISO diisobutyl phthalate results in decreased expression of HMGCR mRNA CTD PMID:28655647 PMID:33983380 NCBI chr 5:75,336,334...75,362,116
Ensembl chr 5:75,336,329...75,364,001
JBrowse link
G HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 decreases expression ISO diisobutyl phthalate results in decreased expression of HMGCS1 mRNA CTD PMID:28655647 PMID:33983380 NCBI chr 5:43,287,470...43,313,477
Ensembl chr 5:43,287,470...43,313,512
JBrowse link
G HOXB8 homeobox B8 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HOXB8 mRNA CTD PMID:31199487 NCBI chr17:48,612,346...48,619,531
Ensembl chr17:48,611,377...48,615,292
JBrowse link
G HOXD3 homeobox D3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HOXD3 mRNA CTD PMID:31199487 NCBI chr 2:176,157,307...176,173,102
Ensembl chr 2:176,136,612...176,173,102
JBrowse link
G HSD17B3 hydroxysteroid 17-beta dehydrogenase 3 increases expression ISO diisobutyl phthalate results in increased expression of HSD17B3 mRNA CTD PMID:28655647 NCBI chr 9:96,235,306...96,313,987
Ensembl chr 9:96,235,306...96,302,176
JBrowse link
G HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD3B1 mRNA CTD PMID:28013214 NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
JBrowse link
G HSPA12A heat shock protein family A (Hsp70) member 12A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA CTD PMID:31199487 NCBI chr10:116,671,192...116,853,272
Ensembl chr10:116,671,192...116,850,251
JBrowse link
G IDO2 indoleamine 2,3-dioxygenase 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of IDO2 mRNA CTD PMID:31199487 NCBI chr 8:39,934,651...40,016,392
Ensembl chr 8:39,934,614...40,016,391
JBrowse link
G IL6 interleukin 6 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of IL6 mRNA] CTD PMID:33316053 NCBI chr 7:22,725,889...22,732,002
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G INHA inhibin subunit alpha decreases expression ISO diisobutyl phthalate results in decreased expression of INHA mRNA CTD PMID:33983380 NCBI chr 2:219,572,310...219,575,711
Ensembl chr 2:219,569,162...219,575,711
JBrowse link
G INSIG1 insulin induced gene 1 decreases expression ISO diisobutyl phthalate results in decreased expression of INSIG1 mRNA CTD PMID:33983380 NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
JBrowse link
G INSL3 insulin like 3 decreases expression
multiple interactions
ISO diisobutyl phthalate results in decreased expression of INSL3 mRNA
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of INSL3 mRNA
CTD PMID:22112501 PMID:33983380 NCBI chr19:17,816,512...17,821,519
Ensembl chr19:17,816,512...17,821,574
JBrowse link
G KIF5C kinesin family member 5C multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5C mRNA CTD PMID:31199487 NCBI chr 2:148,875,227...149,026,759
Ensembl chr 2:148,875,227...149,026,759
JBrowse link
G L1CAM L1 cell adhesion molecule multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of L1CAM mRNA CTD PMID:31199487 NCBI chr  X:153,861,514...153,886,173
Ensembl chr  X:153,861,514...153,886,173
JBrowse link
G LCN2 lipocalin 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA CTD PMID:31199487 NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
JBrowse link
G LDLR low density lipoprotein receptor decreases expression ISO diisobutyl phthalate results in decreased expression of LDLR mRNA CTD PMID:33983380 NCBI chr19:11,089,432...11,133,820
Ensembl chr19:11,089,462...11,133,820
JBrowse link
G LHCGR luteinizing hormone/choriogonadotropin receptor multiple interactions ISO [diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of LHCGR mRNA CTD PMID:33983380 NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730
JBrowse link
G LONRF2 LON peptidase N-terminal domain and ring finger 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LONRF2 mRNA CTD PMID:31199487 NCBI chr 2:100,271,875...100,322,501
Ensembl chr 2:100,271,875...100,322,501
JBrowse link
G LPL lipoprotein lipase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of LPL mRNA CTD PMID:30768133 NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
JBrowse link
G LRRC4B leucine rich repeat containing 4B multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LRRC4B mRNA CTD PMID:31199487 NCBI chr19:50,516,892...50,568,435
Ensembl chr19:50,516,892...50,568,435
JBrowse link
G LYNX1 Ly6/neurotoxin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LYNX1 mRNA CTD PMID:31199487 NCBI chr 8:142,771,197...142,777,872
Ensembl chr 8:142,771,197...142,777,810
JBrowse link
G MAP6 microtubule associated protein 6 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MAP6 mRNA CTD PMID:31199487 NCBI chr11:75,586,914...75,669,038
Ensembl chr11:75,586,918...75,669,038
JBrowse link
G MAPT microtubule associated protein tau multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MAPT mRNA CTD PMID:31199487 NCBI chr17:45,894,538...46,028,334
Ensembl chr17:45,894,527...46,028,334
JBrowse link
G MIR141 microRNA 141 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR141 CTD PMID:31199487 NCBI chr12:6,964,097...6,964,191
Ensembl chr12:6,964,097...6,964,191
JBrowse link
G MIR184 microRNA 184 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR184 CTD PMID:31199487 NCBI chr15:79,209,788...79,209,871
Ensembl chr15:79,209,788...79,209,871
JBrowse link
G MLLT11 MLLT11 transcription factor 7 cofactor multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MLLT11 mRNA CTD PMID:31199487 NCBI chr 1:151,060,397...151,069,544
Ensembl chr 1:151,060,397...151,069,544
JBrowse link
G MMP14 matrix metallopeptidase 14 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP14 mRNA] CTD PMID:33316053 NCBI chr14:22,836,585...22,847,758
Ensembl chr14:22,836,560...22,849,041
JBrowse link
G MMP16 matrix metallopeptidase 16 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP16 mRNA] CTD PMID:33316053 NCBI chr 8:88,032,009...88,327,483
Ensembl chr 8:88,032,011...88,328,025
JBrowse link
G MMP9 matrix metallopeptidase 9 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of MMP9 mRNA] CTD PMID:33316053 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
JBrowse link
G MVD mevalonate diphosphate decarboxylase decreases expression ISO diisobutyl phthalate results in decreased expression of MVD mRNA CTD PMID:33983380 NCBI chr16:88,651,935...88,663,153
Ensembl chr16:88,651,935...88,663,161
JBrowse link
G NCS1 neuronal calcium sensor 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NCS1 mRNA CTD PMID:31199487 NCBI chr 9:130,172,404...130,237,303
Ensembl chr 9:130,172,404...130,237,303
JBrowse link
G NDRG4 NDRG family member 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NDRG4 mRNA CTD PMID:31199487 NCBI chr16:58,463,704...58,515,403
Ensembl chr16:58,462,846...58,513,628
JBrowse link
G NEFH neurofilament heavy chain multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFH mRNA CTD PMID:31199487 NCBI chr22:29,480,218...29,491,390
Ensembl chr22:29,480,218...29,491,390
JBrowse link
G NEFL neurofilament light chain multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFL mRNA CTD PMID:31199487 NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
JBrowse link
G NELL1 neural EGFL like 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NELL1 mRNA CTD PMID:31199487 NCBI chr11:20,669,551...21,575,686
Ensembl chr11:20,669,551...21,575,686
JBrowse link
G NGFR nerve growth factor receptor multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NGFR mRNA CTD PMID:31199487 NCBI chr17:49,495,293...49,515,008
Ensembl chr17:49,495,293...49,515,008
JBrowse link
G NR0B1 nuclear receptor subfamily 0 group B member 1 decreases expression ISO diisobutyl phthalate results in decreased expression of NR0B1 mRNA CTD PMID:33983380 NCBI chr  X:30,304,206...30,309,390
Ensembl chr  X:30,304,206...30,309,390
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 increases activity EXP diisobutyl phthalate results in increased activity of NR1I2 protein alternative form CTD PMID:21227907 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 multiple interactions
affects binding
increases activity
EXP [diisobutyl phthalate co-treated with Androstanols] results in increased activity of NR1I3 protein alternative form
diisobutyl phthalate binds to NR1I3 protein
diisobutyl phthalate results in increased activity of NR1I3 protein alternative form
CTD PMID:21227907 PMID:25938866 NCBI chr 1:161,229,666...161,238,623
Ensembl chr 1:161,229,666...161,238,244
JBrowse link
G NRXN2 neurexin 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NRXN2 mRNA CTD PMID:31199487 NCBI chr11:64,606,174...64,723,197
Ensembl chr11:64,606,174...64,723,197
JBrowse link
G NSDHL NAD(P) dependent steroid dehydrogenase-like decreases expression ISO diisobutyl phthalate results in decreased expression of NSDHL mRNA CTD PMID:33983380 NCBI chr  X:152,831,001...152,869,729
Ensembl chr  X:152,830,967...152,869,729
JBrowse link
G NSG1 neuronal vesicle trafficking associated 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NSG1 mRNA CTD PMID:31199487 NCBI chr 4:4,386,532...4,419,058
Ensembl chr 4:4,348,140...4,419,058
JBrowse link
G NSG2 neuronal vesicle trafficking associated 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NSG2 mRNA CTD PMID:31199487 NCBI chr 5:174,045,706...174,109,179
Ensembl chr 5:174,045,706...174,243,501
JBrowse link
G OLFM1 olfactomedin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of OLFM1 mRNA CTD PMID:31199487 NCBI chr 9:135,075,505...135,121,184
Ensembl chr 9:135,075,422...135,121,180
JBrowse link
G PCP4 Purkinje cell protein 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PCP4 mRNA CTD PMID:31199487 NCBI chr21:39,867,438...39,929,392
Ensembl chr21:39,867,438...39,929,397
JBrowse link
G PGR progesterone receptor multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PGR mRNA] CTD PMID:33316053 NCBI chr11:101,029,624...101,130,681
Ensembl chr11:101,029,624...101,129,813
JBrowse link
G PLAT plasminogen activator, tissue type multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PLAT mRNA] CTD PMID:33316053 NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
JBrowse link
G PLPPR3 phospholipid phosphatase related 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLPPR3 mRNA CTD PMID:31199487 NCBI chr19:810,966...824,244
Ensembl chr19:812,488...821,955
JBrowse link
G PLS1 plastin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PLS1 mRNA CTD PMID:31199487 NCBI chr 3:142,596,393...142,713,664
Ensembl chr 3:142,596,393...142,713,664
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PPARA mRNA CTD PMID:28013214 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,756
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma multiple interactions
increases expression
increases activity
EXP diisobutyl phthalate binds to and results in increased activity of PPARG protein
diisobutyl phthalate results in increased expression of PPARG protein
diisobutyl phthalate results in increased activity of PPARG protein
CTD PMID:24155963 PMID:26172262 PMID:27633901 PMID:29061543 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
JBrowse link
G PPP2R2B protein phosphatase 2 regulatory subunit Bbeta multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PPP2R2B mRNA CTD PMID:31199487 NCBI chr 5:146,580,742...147,081,520
Ensembl chr 5:146,580,742...147,084,784
JBrowse link
G PRIMA1 proline rich membrane anchor 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PRIMA1 mRNA CTD PMID:31199487 NCBI chr14:93,718,298...93,789,029
Ensembl chr14:93,718,298...93,788,485
JBrowse link
G PRPH peripherin multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PRPH mRNA CTD PMID:31199487 NCBI chr12:49,295,144...49,298,698
Ensembl chr12:49,293,252...49,298,686
JBrowse link
G PTGES prostaglandin E synthase multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PTGES mRNA CTD PMID:31199487 NCBI chr 9:129,738,349...129,753,042
Ensembl chr 9:129,738,331...129,753,042
JBrowse link
G PTGR1 prostaglandin reductase 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PTGR1 mRNA CTD PMID:31199487 NCBI chr 9:111,549,722...111,599,855
Ensembl chr 9:111,549,722...111,599,893
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PTGS2 mRNA] CTD PMID:33316053 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G PTPRN protein tyrosine phosphatase receptor type N multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PTPRN mRNA CTD PMID:31199487 NCBI chr 2:219,289,623...219,309,401
Ensembl chr 2:219,289,623...219,309,648
JBrowse link
G QSOX1 quiescin sulfhydryl oxidase 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of QSOX1 mRNA CTD PMID:31199487 NCBI chr 1:180,154,869...180,204,030
Ensembl chr 1:180,154,869...180,204,030
JBrowse link
G RAB3B RAB3B, member RAS oncogene family multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB3B mRNA CTD PMID:31199487 NCBI chr 1:51,907,956...51,990,700
Ensembl chr 1:51,907,956...51,990,700
JBrowse link
G RAB6B RAB6B, member RAS oncogene family multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RAB6B mRNA CTD PMID:31199487 NCBI chr 3:133,824,235...133,895,882
Ensembl chr 3:133,824,235...133,895,882
JBrowse link
G RASSF4 Ras association domain family member 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RASSF4 mRNA CTD PMID:31199487 NCBI chr10:44,959,753...44,995,891
Ensembl chr10:44,959,407...44,995,891
JBrowse link
G RESP18 regulated endocrine specific protein 18 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RESP18 mRNA CTD PMID:31199487 NCBI chr 2:219,327,407...219,334,535
Ensembl chr 2:219,327,407...219,333,177
JBrowse link
G RNF183 ring finger protein 183 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of RNF183 mRNA CTD PMID:31199487 NCBI chr 9:113,297,093...113,303,877
Ensembl chr 9:113,297,093...113,303,376
JBrowse link
G RTN1 reticulon 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RTN1 mRNA CTD PMID:31199487 NCBI chr14:59,595,976...59,871,288
Ensembl chr14:59,595,976...59,870,776
JBrowse link
G RTN4R reticulon 4 receptor multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of RTN4R mRNA CTD PMID:31199487 NCBI chr22:20,241,415...20,268,318
Ensembl chr22:20,241,415...20,283,246
JBrowse link
G RXRG retinoid X receptor gamma decreases expression ISO diisobutyl phthalate results in decreased expression of RXRG mRNA CTD PMID:22112501 NCBI chr 1:165,400,922...165,445,126
Ensembl chr 1:165,400,922...165,445,355
JBrowse link
G SCARB1 scavenger receptor class B member 1 decreases expression
multiple interactions
ISO diisobutyl phthalate results in decreased expression of SCARB1 mRNA
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of SCARB1 mRNA
CTD PMID:22112501 PMID:28655647 PMID:33983380 NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
JBrowse link
G SCG3 secretogranin III multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SCG3 mRNA CTD PMID:31199487 NCBI chr15:51,681,503...51,721,026
Ensembl chr15:51,681,492...51,721,026
JBrowse link
G SCN3B sodium voltage-gated channel beta subunit 3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SCN3B mRNA CTD PMID:31199487 NCBI chr11:123,629,187...123,654,624
Ensembl chr11:123,629,187...123,655,244
JBrowse link
G SCRN1 secernin 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SCRN1 mRNA CTD PMID:31199487 NCBI chr 7:29,920,103...29,990,289
Ensembl chr 7:29,920,104...29,990,289
JBrowse link
G SERPINB2 serpin family B member 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINB2 mRNA] CTD PMID:33316053 NCBI chr18:63,887,705...63,903,890
Ensembl chr18:63,871,692...63,903,888
JBrowse link
G SERPINE1 serpin family E member 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINE1 mRNA] CTD PMID:33316053 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
JBrowse link
G SH3GL3 SH3 domain containing GRB2 like 3, endophilin A3 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3GL3 mRNA CTD PMID:31199487 NCBI chr15:83,447,123...83,618,743
Ensembl chr15:83,447,228...83,618,743
JBrowse link
G SH3TC2 SH3 domain and tetratricopeptide repeats 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SH3TC2 mRNA CTD PMID:31199487 NCBI chr 5:148,982,150...149,063,062
Ensembl chr 5:148,923,639...149,063,163
JBrowse link
G SHC2 SHC adaptor protein 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SHC2 mRNA CTD PMID:31199487 NCBI chr19:416,589...461,033
Ensembl chr19:416,589...461,033
JBrowse link
G SLC13A2 solute carrier family 13 member 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SLC13A2 mRNA CTD PMID:31199487 NCBI chr17:28,473,357...28,497,781
Ensembl chr17:28,473,293...28,497,781
JBrowse link
G SLC29A4 solute carrier family 29 member 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SLC29A4 mRNA CTD PMID:31199487 NCBI chr 7:5,274,311...5,306,912
Ensembl chr 7:5,274,369...5,306,912
JBrowse link
G SLC5A7 solute carrier family 5 member 7 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SLC5A7 mRNA CTD PMID:31199487 NCBI chr 2:107,986,524...108,014,497
Ensembl chr 2:107,986,523...108,013,994
JBrowse link
G SLCO2A1 solute carrier organic anion transporter family member 2A1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of SLCO2A1 mRNA] CTD PMID:33316053 NCBI chr 3:133,932,701...134,029,955
Ensembl chr 3:133,932,701...134,052,184
JBrowse link
G SMIM24 small integral membrane protein 24 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SMIM24 mRNA CTD PMID:31199487 NCBI chr19:3,473,986...3,480,525
Ensembl chr19:3,473,986...3,480,525
JBrowse link
G SNHG11 small nucleolar RNA host gene 11 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SNHG11 mRNA CTD PMID:31199487 NCBI chr20:38,446,654...38,450,921
Ensembl chr20:38,446,343...38,450,940
JBrowse link
G SOD1 superoxide dismutase 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SOD1 mRNA CTD PMID:28013214 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
JBrowse link
G SOX9 SRY-box transcription factor 9 increases expression ISO diisobutyl phthalate results in increased expression of SOX9 mRNA CTD PMID:22112501 NCBI chr17:72,121,020...72,126,416
Ensembl chr17:72,121,020...72,126,416
JBrowse link
G STAR steroidogenic acute regulatory protein decreases expression
multiple interactions
ISO diisobutyl phthalate results in decreased expression of STAR mRNA; diisobutyl phthalate results in decreased expression of STAR protein
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of STAR mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STAR mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of STAR mRNA
CTD PMID:16458459 PMID:21633115 PMID:22112501 PMID:28013214 PMID:28655647 More... NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
JBrowse link
G STK32C serine/threonine kinase 32C multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA CTD PMID:31199487 NCBI chr10:132,207,482...132,332,559
Ensembl chr10:132,207,492...132,331,847
JBrowse link
G STMN4 stathmin 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STMN4 mRNA CTD PMID:31199487 NCBI chr 8:27,235,308...27,258,865
Ensembl chr 8:27,235,323...27,258,420
JBrowse link
G SYT11 synaptotagmin 11 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SYT11 mRNA CTD PMID:31199487 NCBI chr 1:155,859,502...155,885,199
Ensembl chr 1:155,859,567...155,885,199
JBrowse link
G SYT5 synaptotagmin 5 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of SYT5 mRNA CTD PMID:31199487 NCBI chr19:55,171,196...55,180,441
Ensembl chr19:55,171,196...55,180,289
JBrowse link
G TBX2 T-box transcription factor 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TBX2 mRNA CTD PMID:31199487 NCBI chr17:61,399,843...61,409,466
Ensembl chr17:61,399,843...61,409,466
JBrowse link
G TCF23 transcription factor 23 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TCF23 mRNA CTD PMID:31199487 NCBI chr 2:27,148,892...27,156,974
Ensembl chr 2:27,149,004...27,156,974
JBrowse link
G TCTE1 t-complex-associated-testis-expressed 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TCTE1 mRNA CTD PMID:31199487 NCBI chr 6:44,278,734...44,297,805
Ensembl chr 6:44,278,734...44,297,698
JBrowse link
G THRB thyroid hormone receptor beta multiple interactions EXP diisobutyl phthalate binds to and results in decreased activity of THRB protein CTD PMID:27633901 NCBI chr 3:24,117,153...24,495,708
Ensembl chr 3:24,117,153...24,495,756
JBrowse link
G TIMP1 TIMP metallopeptidase inhibitor 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of TIMP1 mRNA] CTD PMID:33316053 NCBI chr  X:47,582,408...47,586,789
Ensembl chr  X:47,582,408...47,586,789
JBrowse link
G TM7SF2 transmembrane 7 superfamily member 2 decreases expression ISO diisobutyl phthalate results in decreased expression of TM7SF2 mRNA CTD PMID:33983380 NCBI chr11:65,111,872...65,116,230
Ensembl chr11:65,111,845...65,116,384
JBrowse link
G TMEFF2 transmembrane protein with EGF like and two follistatin like domains 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEFF2 mRNA CTD PMID:31199487 NCBI chr 2:191,948,300...192,194,933
Ensembl chr 2:191,949,043...192,194,933
JBrowse link
G TMEM130 transmembrane protein 130 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM130 mRNA CTD PMID:31199487 NCBI chr 7:98,846,490...98,870,014
Ensembl chr 7:98,846,488...98,870,771
JBrowse link
G TMEM35A transmembrane protein 35A multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM35A mRNA CTD PMID:31199487 NCBI chr  X:101,078,879...101,096,367
Ensembl chr  X:101,078,879...101,096,367
JBrowse link
G TMEM63C transmembrane protein 63C multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TMEM63C mRNA CTD PMID:31199487 NCBI chr14:77,181,798...77,259,495
Ensembl chr14:77,116,568...77,259,495
JBrowse link
G TRPC6 transient receptor potential cation channel subfamily C member 6 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TRPC6 mRNA CTD PMID:31199487 NCBI chr11:101,451,470...101,584,007
Ensembl chr11:101,451,564...101,872,562
JBrowse link
G TTYH1 tweety family member 1 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TTYH1 mRNA CTD PMID:31199487 NCBI chr19:54,415,464...54,436,904
Ensembl chr19:54,415,219...54,436,904
JBrowse link
G TUBB2B tubulin beta 2B class IIb multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TUBB2B mRNA CTD PMID:31199487 NCBI chr 6:3,224,277...3,227,653
Ensembl chr 6:3,223,324...3,231,730
JBrowse link
G TUBB3 tubulin beta 3 class III multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TUBB3 mRNA CTD PMID:31199487 NCBI chr16:89,921,925...89,936,097
Ensembl chr16:89,921,392...89,938,761
JBrowse link
G TUBB4A tubulin beta 4A class IVa multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of TUBB4A mRNA CTD PMID:31199487 NCBI chr19:6,494,319...6,502,848
Ensembl chr19:6,494,319...6,502,848
JBrowse link
G UBASH3B ubiquitin associated and SH3 domain containing B multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBASH3B mRNA CTD PMID:31199487 NCBI chr11:122,655,722...122,814,473
Ensembl chr11:122,655,722...122,814,473
JBrowse link
G UBXN11 UBX domain protein 11 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of UBXN11 mRNA CTD PMID:31199487 NCBI chr 1:26,282,282...26,318,355
Ensembl chr 1:26,281,328...26,318,363
JBrowse link
G WNT4 Wnt family member 4 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA] CTD PMID:33316053 NCBI chr 1:22,117,308...22,143,981
Ensembl chr 1:22,117,313...22,143,969
JBrowse link
G WNT6 Wnt family member 6 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA CTD PMID:31199487 NCBI chr 2:218,859,805...218,874,233
Ensembl chr 2:218,859,805...218,874,233
JBrowse link
G WNT9B Wnt family member 9B multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT9B mRNA CTD PMID:31199487 NCBI chr17:46,833,201...46,886,738
Ensembl chr17:46,833,201...46,886,730
JBrowse link
G WT1 WT1 transcription factor multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 NCBI chr11:32,387,775...32,435,539
Ensembl chr11:32,387,775...32,435,564
JBrowse link
G ZCCHC12 zinc finger CCHC-type containing 12 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ZCCHC12 mRNA CTD PMID:31199487 NCBI chr  X:118,823,824...118,826,968
Ensembl chr  X:118,823,824...118,826,968
JBrowse link
G ZFAT zinc finger and AT-hook domain containing multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ZFAT mRNA CTD PMID:31199487 NCBI chr 8:134,477,788...134,713,031
Ensembl chr 8:134,477,788...134,713,049
JBrowse link
G ZP2 zona pellucida glycoprotein 2 multiple interactions ISO [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ZP2 mRNA CTD PMID:31199487 NCBI chr16:21,197,450...21,214,510
Ensembl chr16:21,197,450...21,214,510
JBrowse link
dinitrogen term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ATG13 autophagy related 13 multiple interactions EXP ATG13 protein inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]; ATG13 protein promotes the reaction [bafilomycin A inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]]; Nitrogen deficiency inhibits the reaction [ATG13 protein results in increased expression of ULK1 protein]; Nitrogen deficiency promotes the reaction [ATG13 protein results in decreased expression of SQSTM1 protein] CTD PMID:27629431 NCBI chr11:46,617,527...46,674,518
Ensembl chr11:46,617,527...46,674,818
JBrowse link
G ATG4B autophagy related 4B cysteine peptidase decreases expression EXP Nitrogen deficiency results in decreased expression of ATG4B protein CTD PMID:27629431 NCBI chr 2:241,637,659...241,673,857
Ensembl chr 2:241,637,213...241,673,857
JBrowse link
G ATG7 autophagy related 7 multiple interactions EXP ATG7 protein inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]; ATG7 protein promotes the reaction [bafilomycin A inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]] CTD PMID:27629431 NCBI chr 3:11,272,348...11,564,652
Ensembl chr 3:11,272,309...11,557,665
JBrowse link
G CCL2 C-C motif chemokine ligand 2 multiple interactions EXP [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of CCL2 protein CTD PMID:30711708 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,218...34,257,203
JBrowse link
G CCL5 C-C motif chemokine ligand 5 multiple interactions EXP [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of CCL5 protein CTD PMID:30711708 NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
JBrowse link
G CDK4 cyclin dependent kinase 4 multiple interactions EXP [Nanotubes, Carbon co-treated with Nitrogen] results in increased expression of CDK4 protein CTD PMID:25797581 NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
JBrowse link
G CSF2 colony stimulating factor 2 multiple interactions EXP [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of CSF2 protein CTD PMID:30711708 NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
JBrowse link
G CSF3 colony stimulating factor 3 multiple interactions EXP [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of CSF3 protein CTD PMID:30711708 NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
JBrowse link
G CXCL1 C-X-C motif chemokine ligand 1 multiple interactions EXP [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of CXCL1 protein CTD PMID:30711708 NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 multiple interactions EXP [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of CXCL8 protein CTD PMID:30711708 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,541...73,743,716
JBrowse link
G GRK1 G protein-coupled receptor kinase 1 multiple interactions ISO [Nitrogen co-treated with Iodoacetic Acid] results in increased expression of GRK1 mRNA; Octreotide affects the reaction [SSTR1 protein affects the reaction [[Nitrogen co-treated with Iodoacetic Acid] results in increased expression of GRK1 mRNA]]; Octreotide inhibits the reaction [[Nitrogen co-treated with Iodoacetic Acid] results in increased expression of GRK1 mRNA]; SSTR1 protein affects the reaction [[Nitrogen co-treated with Iodoacetic Acid] results in increased expression of GRK1 mRNA] CTD PMID:18624922 NCBI chr13:113,645,771...113,737,736
Ensembl chr13:113,667,219...113,737,736
JBrowse link
G IL6 interleukin 6 multiple interactions EXP [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of IL6 protein CTD PMID:30711708 NCBI chr 7:22,725,889...22,732,002
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions EXP [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased phosphorylation of MAPK1 protein CTD PMID:30711708 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions EXP [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased phosphorylation of MAPK3 protein CTD PMID:30711708 NCBI chr16:30,114,105...30,123,309
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MIF macrophage migration inhibitory factor multiple interactions EXP [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of MIF protein CTD PMID:30711708 NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
JBrowse link
G RGS1 regulator of G protein signaling 1 multiple interactions ISO [Nitrogen co-treated with Iodoacetic Acid] results in increased expression of RGS1 mRNA; Octreotide inhibits the reaction [[Nitrogen co-treated with Iodoacetic Acid] results in increased expression of RGS1 mRNA]; SSTR1 protein affects the reaction [[Nitrogen co-treated with Iodoacetic Acid] results in increased expression of RGS1 mRNA] CTD PMID:18624922 NCBI chr 1:192,575,773...192,580,024
Ensembl chr 1:192,575,763...192,580,024
JBrowse link
G SERPINE1 serpin family E member 1 multiple interactions EXP [Silver Compounds binds to [Nitrogen binds to titanium dioxide]] which results in increased secretion of SERPINE1 protein CTD PMID:30711708 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
JBrowse link
G SQSTM1 sequestosome 1 decreases expression
multiple interactions
EXP Nitrogen deficiency results in decreased expression of SQSTM1 protein
bafilomycin A inhibits the reaction [Nitrogen deficiency results in decreased expression of SQSTM1 protein]; Nitrogen deficiency promotes the reaction [ATG13 protein results in decreased expression of SQSTM1 protein]
CTD PMID:27629431 NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
JBrowse link
G SSTR1 somatostatin receptor 1 multiple interactions ISO Octreotide affects the reaction [SSTR1 protein affects the reaction [[Nitrogen co-treated with Iodoacetic Acid] results in increased expression of GRK1 mRNA]]; SSTR1 protein affects the reaction [[Nitrogen co-treated with Iodoacetic Acid] results in increased expression of GRK1 mRNA]; SSTR1 protein affects the reaction [[Nitrogen co-treated with Iodoacetic Acid] results in increased expression of RGS1 mRNA] CTD PMID:18624922 NCBI chr14:38,207,904...38,213,067
Ensembl chr14:38,207,904...38,213,067
JBrowse link
G TXNRD1 thioredoxin reductase 1 multiple interactions ISO Nitrogen inhibits the reaction [myricetin results in decreased activity of TXNRD1 protein modified form]; Nitrogen inhibits the reaction [Quercetin results in decreased activity of TXNRD1 protein modified form] CTD PMID:16618767 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
JBrowse link
G ULK1 unc-51 like autophagy activating kinase 1 multiple interactions
increases expression
EXP Antimycin A inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]; ATG13 protein inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]; ATG13 protein promotes the reaction [bafilomycin A inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]]; ATG7 protein inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]; ATG7 protein promotes the reaction [bafilomycin A inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]]; bafilomycin A inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]; Nitrogen deficiency inhibits the reaction [Antimycin A results in increased expression of ULK1 protein]; Nitrogen deficiency inhibits the reaction [ATG13 protein results in increased expression of ULK1 protein]; Nitrogen deficiency results in decreased expression of and results in decreased phosphorylation of and results in increased cleavage of and affects the localization of ULK1 protein
Nitrogen deficiency results in increased expression of ULK1 mRNA
CTD PMID:27629431 NCBI chr12:131,894,622...131,923,150
Ensembl chr12:131,894,622...131,923,150
JBrowse link
dinitrogen oxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CNTF ciliary neurotrophic factor multiple interactions
decreases activity
EXP
ISO
Nitrous Oxide inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT1 protein]; Nitrous Oxide inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT3 protein]
Nitrous Oxide inhibits the reaction [CNTF protein results in increased activity of STAT3 protein]
Nitrous Oxide results in decreased activity of CNTF protein
CTD PMID:15748169 NCBI chr11:58,622,665...58,625,733
Ensembl chr11:58,622,665...58,625,733
JBrowse link
G GABRA4 gamma-aminobutyric acid type A receptor subunit alpha4 multiple interactions ISO [Isoflurane co-treated with Nitrous Oxide] affects the expression of GABRA4 mRNA CTD PMID:16733821 NCBI chr 4:46,918,900...46,993,581
Ensembl chr 4:46,918,900...46,993,581
JBrowse link
G GRIN2A glutamate ionotropic receptor NMDA type subunit 2A multiple interactions ISO GRIN2A protein affects the susceptibility to [Nitrous Oxide co-treated with sevoflurane] CTD PMID:15731593 NCBI chr16:9,753,404...10,182,928
Ensembl chr16:9,753,404...10,182,928
JBrowse link
G MTR 5-methyltetrahydrofolate-homocysteine methyltransferase decreases activity EXP Nitrous Oxide results in decreased activity of MTR protein CTD PMID:18472229 NCBI chr 1:236,794,304...236,903,981
Ensembl chr 1:236,795,260...236,921,278
JBrowse link
G PLA2G7 phospholipase A2 group VII affects expression EXP Nitrous Oxide affects the expression of PLA2G7 CTD PMID:21356620 NCBI chr 6:46,700,558...46,735,836
Ensembl chr 6:46,704,201...46,735,693
JBrowse link
G POMC proopiomelanocortin increases secretion ISO Nitrous Oxide results in increased secretion of POMC protein CTD PMID:2846107 NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
JBrowse link
G STAT1 signal transducer and activator of transcription 1 multiple interactions EXP Nitrous Oxide inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT1 protein] CTD PMID:15748169 NCBI chr 2:190,968,989...191,014,197
Ensembl chr 2:190,908,460...191,020,960
JBrowse link
G STAT3 signal transducer and activator of transcription 3 multiple interactions ISO
EXP
Nitrous Oxide inhibits the reaction [CNTF protein results in increased activity of STAT3 protein]
Nitrous Oxide inhibits the reaction [CNTF protein results in increased phosphorylation of and results in increased activity of STAT3 protein]
CTD PMID:15748169 NCBI chr17:42,313,324...42,388,502
Ensembl chr17:42,313,324...42,388,540
JBrowse link
fenpyroximate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCA1 ATP binding cassette subfamily A member 1 increases expression EXP fenpyroximate results in increased expression of ABCA1 mRNA CTD PMID:33512557 NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
JBrowse link
G AKR1B1 aldo-keto reductase family 1 member B decreases expression EXP fenpyroximate results in decreased expression of AKR1B1 mRNA CTD PMID:33512557 NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
JBrowse link
G AKR7A2 aldo-keto reductase family 7 member A2 decreases expression EXP fenpyroximate results in decreased expression of AKR7A2 mRNA CTD PMID:33512557 NCBI chr 1:19,302,708...19,312,146
Ensembl chr 1:19,303,965...19,312,144
JBrowse link
G AKT1 AKT serine/threonine kinase 1 decreases expression EXP fenpyroximate results in decreased expression of AKT1 mRNA CTD PMID:33512557 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G ALDH9A1 aldehyde dehydrogenase 9 family member A1 decreases expression EXP fenpyroximate results in decreased expression of ALDH9A1 mRNA CTD PMID:33512557 NCBI chr 1:165,662,216...165,698,562
Ensembl chr 1:165,662,216...165,698,863
JBrowse link
G AMER1 APC membrane recruitment protein 1 decreases expression EXP fenpyroximate results in decreased expression of AMER1 mRNA CTD PMID:33512557 NCBI chr  X:64,185,117...64,205,708
Ensembl chr  X:64,185,117...64,205,708
JBrowse link
G ANO10 anoctamin 10 decreases expression EXP fenpyroximate results in decreased expression of ANO10 mRNA CTD PMID:33512557 NCBI chr 3:43,365,848...43,691,594
Ensembl chr 3:43,354,859...43,691,594
JBrowse link
G AP3M1 adaptor related protein complex 3 subunit mu 1 decreases expression EXP fenpyroximate results in decreased expression of AP3M1 mRNA CTD PMID:33512557 NCBI chr10:74,120,012...74,151,067
Ensembl chr10:74,120,255...74,150,842
JBrowse link
G APEX1 apurinic/apyrimidinic endodeoxyribonuclease 1 increases expression EXP fenpyroximate results in increased expression of APEX1 mRNA CTD PMID:33512557 NCBI chr14:20,455,226...20,457,767
Ensembl chr14:20,455,191...20,457,772
JBrowse link
G ARG1 arginase 1 decreases expression EXP fenpyroximate results in decreased expression of ARG1 mRNA CTD PMID:32194361 NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
JBrowse link
G ARHGAP9 Rho GTPase activating protein 9 increases expression EXP fenpyroximate results in increased expression of ARHGAP9 mRNA CTD PMID:33512557 NCBI chr12:57,472,262...57,488,824
Ensembl chr12:57,472,264...57,488,814
JBrowse link
G ARRDC4 arrestin domain containing 4 decreases expression EXP fenpyroximate results in decreased expression of ARRDC4 mRNA CTD PMID:33512557 NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833
JBrowse link
G ASNS asparagine synthetase (glutamine-hydrolyzing) increases expression EXP fenpyroximate results in increased expression of ASNS mRNA CTD PMID:33512557 NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
JBrowse link
G ASS1 argininosuccinate synthase 1 increases expression EXP fenpyroximate results in increased expression of ASS1 mRNA CTD PMID:33512557 NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
JBrowse link
G ATF4 activating transcription factor 4 increases expression EXP fenpyroximate results in increased expression of ATF4 mRNA CTD PMID:33512557 NCBI chr22:39,514,494...39,522,686
Ensembl chr22:39,519,695...39,522,683
JBrowse link
G ATF5 activating transcription factor 5 increases expression EXP fenpyroximate results in increased expression of ATF5 mRNA CTD PMID:33512557 NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,928,702...49,933,935
JBrowse link
G ATMIN ATM interactor decreases expression EXP fenpyroximate results in decreased expression of ATMIN mRNA CTD PMID:33512557 NCBI chr16:81,035,842...81,047,350
Ensembl chr16:81,035,842...81,047,350
JBrowse link
G ATP5F1B ATP synthase F1 subunit beta decreases expression EXP fenpyroximate results in decreased expression of ATP5F1B mRNA CTD PMID:33512557 NCBI chr12:56,638,175...56,645,984
Ensembl chr12:56,638,175...56,645,984
JBrowse link
G ATP5F1C ATP synthase F1 subunit gamma decreases expression EXP fenpyroximate results in decreased expression of ATP5F1C mRNA CTD PMID:33512557 NCBI chr10:7,788,159...7,807,801
Ensembl chr10:7,788,147...7,807,815
JBrowse link
G ATP6V1B2 ATPase H+ transporting V1 subunit B2 decreases expression EXP fenpyroximate results in decreased expression of ATP6V1B2 mRNA CTD PMID:33512557 NCBI chr 8:20,197,375...20,226,852
Ensembl chr 8:20,197,381...20,226,819
JBrowse link
G AURKA aurora kinase A increases expression EXP fenpyroximate results in increased expression of AURKA mRNA CTD PMID:33512557 NCBI chr20:56,369,390...56,392,308
Ensembl chr20:56,369,389...56,392,337
JBrowse link
G B2M beta-2-microglobulin increases expression EXP fenpyroximate results in increased expression of B2M mRNA CTD PMID:33512557 NCBI chr15:44,711,492...44,718,145
Ensembl chr15:44,711,487...44,718,851
JBrowse link
G B3GALT6 beta-1,3-galactosyltransferase 6 decreases expression EXP fenpyroximate results in decreased expression of B3GALT6 mRNA CTD PMID:33512557 NCBI chr 1:1,232,237...1,235,041
Ensembl chr 1:1,232,237...1,235,041
JBrowse link
G BCL2L13 BCL2 like 13 decreases expression EXP fenpyroximate results in decreased expression of BCL2L13 mRNA CTD PMID:33512557 NCBI chr22:17,628,855...17,730,855
Ensembl chr22:17,628,855...17,730,855
JBrowse link
G BIRC5 baculoviral IAP repeat containing 5 increases expression EXP fenpyroximate results in increased expression of BIRC5 mRNA CTD PMID:33512557 NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
JBrowse link
G BMF Bcl2 modifying factor decreases expression EXP fenpyroximate results in decreased expression of BMF mRNA CTD PMID:33512557 NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
JBrowse link
G BPHL biphenyl hydrolase like decreases expression EXP fenpyroximate results in decreased expression of BPHL mRNA CTD PMID:33512557 NCBI chr 6:3,118,376...3,153,599
Ensembl chr 6:3,118,374...3,153,578
JBrowse link
G BZW1 basic leucine zipper and W2 domains 1 decreases expression EXP fenpyroximate results in decreased expression of BZW1 mRNA CTD PMID:33512557 NCBI chr 2:200,811,589...200,827,338
Ensembl chr 2:200,810,594...200,827,338
JBrowse link
G C16orf72 chromosome 16 open reading frame 72 increases expression EXP fenpyroximate results in increased expression of C16ORF72 mRNA CTD PMID:33512557 NCBI chr16:9,091,377...9,121,635
Ensembl chr16:9,091,644...9,121,635
JBrowse link
G C2CD5 C2 calcium dependent domain containing 5 decreases expression EXP fenpyroximate results in decreased expression of C2CD5 mRNA CTD PMID:33512557 NCBI chr12:22,448,577...22,544,542
Ensembl chr12:22,448,583...22,544,546
JBrowse link
G CANX calnexin increases expression EXP fenpyroximate results in increased expression of CANX mRNA CTD PMID:33512557 NCBI chr 5:179,678,646...179,731,641
Ensembl chr 5:179,678,628...179,731,641
JBrowse link
G CARS1 cysteinyl-tRNA synthetase 1 increases expression EXP fenpyroximate results in increased expression of CARS1 mRNA CTD PMID:33512557 NCBI chr11:3,000,929...3,057,423
Ensembl chr11:3,000,922...3,057,613
JBrowse link
G CBR1 carbonyl reductase 1 decreases expression EXP fenpyroximate results in decreased expression of CBR1 mRNA CTD PMID:33512557 NCBI chr21:36,070,024...36,073,164
Ensembl chr21:36,069,941...36,073,166
JBrowse link
G CBWD5 COBW domain containing 5 decreases expression EXP fenpyroximate results in decreased expression of CBWD5 mRNA CTD PMID:33512557 NCBI chr 9:65,666,374...65,734,041
Ensembl chr 9:65,668,805...65,734,041
JBrowse link
G CBWD6 COBW domain containing 6 decreases expression EXP fenpyroximate results in decreased expression of CBWD6 mRNA CTD PMID:33512557 NCBI chr 9:41,131,309...41,198,865
Ensembl chr 9:41,131,306...41,199,261
JBrowse link
G CBX4 chromobox 4 increases expression EXP fenpyroximate results in increased expression of CBX4 mRNA CTD PMID:33512557 NCBI chr17:79,833,156...79,839,440
Ensembl chr17:79,833,156...79,839,440
JBrowse link
G CCNB1 cyclin B1 increases expression EXP fenpyroximate results in increased expression of CCNB1 mRNA CTD PMID:33512557 NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
JBrowse link
G CCNB2 cyclin B2 increases expression EXP fenpyroximate results in increased expression of CCNB2 mRNA CTD PMID:33512557 NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
JBrowse link
G CD24 CD24 molecule decreases expression EXP fenpyroximate results in decreased expression of CD24 mRNA CTD PMID:33512557 NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
JBrowse link
G CDH10 cadherin 10 decreases expression EXP fenpyroximate results in decreased expression of CDH10 mRNA CTD PMID:33512557 NCBI chr 5:24,487,100...24,644,978
Ensembl chr 5:24,487,100...24,644,978
JBrowse link
G CDH2 cadherin 2 decreases expression EXP fenpyroximate results in decreased expression of CDH2 mRNA CTD PMID:33512557 NCBI chr18:27,932,878...28,177,130
Ensembl chr18:27,932,879...28,177,946
JBrowse link
G CDK1 cyclin dependent kinase 1 increases expression EXP fenpyroximate results in increased expression of CDK1 mRNA CTD PMID:33512557 NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
JBrowse link
G CDK5R1 cyclin dependent kinase 5 regulatory subunit 1 decreases expression EXP fenpyroximate results in decreased expression of CDK5R1 mRNA CTD PMID:33512557 NCBI chr17:32,485,028...32,491,256
Ensembl chr17:32,486,993...32,491,253
JBrowse link
G CDK6 cyclin dependent kinase 6 increases expression EXP fenpyroximate results in increased expression of CDK6 mRNA CTD PMID:33512557 NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
JBrowse link
G CDKN3 cyclin dependent kinase inhibitor 3 increases expression EXP fenpyroximate results in increased expression of CDKN3 mRNA CTD PMID:33512557 NCBI chr14:54,396,873...54,420,218
Ensembl chr14:54,396,849...54,420,218
JBrowse link
G CEBPB CCAAT enhancer binding protein beta increases expression EXP fenpyroximate results in increased expression of CEBPB mRNA CTD PMID:33512557 NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
JBrowse link
G CEL carboxyl ester lipase decreases expression EXP fenpyroximate results in decreased expression of CEL mRNA CTD PMID:33512557 NCBI chr 9:133,061,981...133,071,861
Ensembl chr 9:133,061,981...133,071,861
JBrowse link
G CFL2 cofilin 2 decreases expression EXP fenpyroximate results in decreased expression of CFL2 mRNA CTD PMID:33512557 NCBI chr14:34,709,113...34,714,593
Ensembl chr14:34,709,113...34,714,823
JBrowse link
G CHAC1 ChaC glutathione specific gamma-glutamylcyclotransferase 1 increases expression EXP fenpyroximate results in increased expression of CHAC1 mRNA CTD PMID:33512557 NCBI chr15:40,942,137...40,956,518
Ensembl chr15:40,952,962...40,956,512
JBrowse link
G CHEK1 checkpoint kinase 1 increases expression EXP fenpyroximate results in increased expression of CHEK1 mRNA CTD PMID:33512557 NCBI chr11:125,624,910...125,676,255
Ensembl chr11:125,625,163...125,676,255
JBrowse link
G CHKA choline kinase alpha increases expression EXP fenpyroximate results in increased expression of CHKA mRNA CTD PMID:33512557 NCBI chr11:68,052,859...68,121,389
Ensembl chr11:68,052,859...68,121,444
JBrowse link
G CKS1B CDC28 protein kinase regulatory subunit 1B increases expression EXP fenpyroximate results in increased expression of CKS1B mRNA CTD PMID:33512557 NCBI chr 1:154,974,681...154,979,251
Ensembl chr 1:154,974,653...154,979,251
JBrowse link
G CKS2 CDC28 protein kinase regulatory subunit 2 increases expression EXP fenpyroximate results in increased expression of CKS2 mRNA CTD PMID:33512557 NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
JBrowse link
G CLIC4 chloride intracellular channel 4 increases expression EXP fenpyroximate results in increased expression of CLIC4 mRNA CTD PMID:33512557 NCBI chr 1:24,745,447...24,844,321
Ensembl chr 1:24,745,382...24,844,321
JBrowse link
G CNPY3 canopy FGF signaling regulator 3 increases expression EXP fenpyroximate results in increased expression of CNPY3 mRNA CTD PMID:33512557 NCBI chr 6:42,928,002...42,939,294
Ensembl chr 6:42,929,192...42,939,294
JBrowse link
G CNTN1 contactin 1 increases expression EXP fenpyroximate results in increased expression of CNTN1 mRNA CTD PMID:33512557 NCBI chr12:40,692,429...41,072,415
Ensembl chr12:40,692,439...41,072,415
JBrowse link
G COA6 cytochrome c oxidase assembly factor 6 increases expression EXP fenpyroximate results in increased expression of COA6 mRNA CTD PMID:33512557 NCBI chr 1:234,373,456...234,385,080
Ensembl chr 1:234,373,456...234,385,080
JBrowse link
G COL16A1 collagen type XVI alpha 1 chain increases expression EXP fenpyroximate results in increased expression of COL16A1 mRNA CTD PMID:33512557 NCBI chr 1:31,652,263...31,704,162
Ensembl chr 1:31,652,263...31,704,319
JBrowse link
G COPS5 COP9 signalosome subunit 5 decreases expression EXP fenpyroximate results in decreased expression of COPS5 mRNA CTD PMID:33512557 NCBI chr 8:67,043,079...67,062,133
Ensembl chr 8:67,043,079...67,083,783
JBrowse link
G CREBRF CREB3 regulatory factor increases expression EXP fenpyroximate results in increased expression of CREBRF mRNA CTD PMID:33512557 NCBI chr 5:173,056,349...173,139,284
Ensembl chr 5:173,056,352...173,139,284
JBrowse link
G CREG1 cellular repressor of E1A stimulated genes 1 increases expression EXP fenpyroximate results in increased expression of CREG1 mRNA CTD PMID:33512557 NCBI chr 1:167,541,013...167,553,762
Ensembl chr 1:167,529,117...167,553,805
JBrowse link
G CRELD2 cysteine rich with EGF like domains 2 increases expression EXP fenpyroximate results in increased expression of CRELD2 mRNA CTD PMID:33512557 NCBI chr22:49,918,634...49,927,540
Ensembl chr22:49,918,167...49,927,540
JBrowse link
G CRTAP cartilage associated protein increases expression EXP fenpyroximate results in increased expression of CRTAP mRNA CTD PMID:33512557 NCBI chr 3:33,114,014...33,147,773
Ensembl chr 3:33,114,014...33,147,773
JBrowse link
G CTNNAL1 catenin alpha like 1 increases expression EXP fenpyroximate results in increased expression of CTNNAL1 mRNA CTD PMID:33512557 NCBI chr 9:108,942,569...109,013,535
Ensembl chr 9:108,942,569...109,013,522
JBrowse link
G CTNND1 catenin delta 1 decreases expression EXP fenpyroximate results in decreased expression of CTNND1 mRNA CTD PMID:33512557 NCBI chr11:57,761,802...57,819,540
Ensembl chr11:57,753,243...57,819,546
JBrowse link
G CTPS1 CTP synthase 1 decreases expression EXP fenpyroximate results in decreased expression of CTPS1 mRNA CTD PMID:33512557 NCBI chr 1:40,979,696...41,012,565
Ensembl chr 1:40,979,688...41,012,565
JBrowse link
G CTTN cortactin decreases expression EXP fenpyroximate results in decreased expression of CTTN mRNA CTD PMID:33512557 NCBI chr11:70,398,529...70,436,579
Ensembl chr11:70,398,404...70,436,584
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 increases expression EXP fenpyroximate results in increased expression of CYP1A1 mRNA CTD PMID:32194361 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 decreases expression EXP fenpyroximate results in decreased expression of CYP2C19 protein CTD PMID:32194361 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
JBrowse link
G CYP7A1 cytochrome P450 family 7 subfamily A member 1 decreases expression EXP fenpyroximate results in decreased expression of CYP7A1 mRNA; fenpyroximate results in decreased expression of CYP7A1 protein CTD PMID:32194361 NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
JBrowse link
G DAAM1 dishevelled associated activator of morphogenesis 1 decreases expression EXP fenpyroximate results in decreased expression of DAAM1 mRNA CTD PMID:33512557 NCBI chr14:59,188,657...59,371,405
Ensembl chr14:59,188,646...59,371,405
JBrowse link
G DAXX death domain associated protein decreases expression EXP fenpyroximate results in decreased expression of DAXX mRNA CTD PMID:33512557 NCBI chr 6:33,318,558...33,322,959
Ensembl chr 6:33,318,558...33,323,016
JBrowse link
G DCK deoxycytidine kinase decreases expression EXP fenpyroximate results in decreased expression of DCK mRNA CTD PMID:33512557 NCBI chr 4:70,993,649...71,030,914
Ensembl chr 4:70,992,538...71,030,914
JBrowse link
G DDIT3 DNA damage inducible transcript 3 increases expression EXP fenpyroximate results in increased expression of DDIT3 mRNA CTD PMID:33512557 NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
JBrowse link
G DEPDC1B DEP domain containing 1B increases expression EXP fenpyroximate results in increased expression of DEPDC1B mRNA CTD PMID:33512557 NCBI chr 5:60,596,912...60,700,166
Ensembl chr 5:60,596,912...60,700,190
JBrowse link
G DFFB DNA fragmentation factor subunit beta decreases expression EXP fenpyroximate results in decreased expression of DFFB mRNA CTD PMID:33512557 NCBI chr 1:3,857,286...3,885,429
Ensembl chr 1:3,857,267...3,885,429
JBrowse link
G DLGAP5 DLG associated protein 5 increases expression EXP fenpyroximate results in increased expression of DLGAP5 mRNA CTD PMID:33512557 NCBI chr14:55,148,130...55,191,585
Ensembl chr14:55,148,112...55,191,608
JBrowse link
G DNAJB14 DnaJ heat shock protein family (Hsp40) member B14 increases expression EXP fenpyroximate results in increased expression of DNAJB14 mRNA CTD PMID:33512557 NCBI chr 4:99,896,248...99,946,713
Ensembl chr 4:99,896,248...99,946,618
JBrowse link
G DNTTIP2 deoxynucleotidyltransferase terminal interacting protein 2 decreases expression EXP fenpyroximate results in decreased expression of DNTTIP2 mRNA CTD PMID:33512557 NCBI chr 1:93,866,284...93,879,206
Ensembl chr 1:93,866,284...93,879,918
JBrowse link
G DRD2 dopamine receptor D2 decreases expression EXP fenpyroximate results in decreased expression of DRD2 mRNA CTD PMID:33512557 NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
JBrowse link
G DUSP4 dual specificity phosphatase 4 increases expression EXP fenpyroximate results in increased expression of DUSP4 mRNA CTD PMID:33512557 NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684
JBrowse link
G EEF1G eukaryotic translation elongation factor 1 gamma decreases expression EXP fenpyroximate results in decreased expression of EEF1G mRNA CTD PMID:33512557 NCBI chr11:62,559,596...62,573,891
Ensembl chr11:62,559,596...62,574,086
JBrowse link
G EGR1 early growth response 1 increases expression EXP fenpyroximate results in increased expression of EGR1 mRNA CTD PMID:33512557 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
JBrowse link
G EIF2S2 eukaryotic translation initiation factor 2 subunit beta increases expression EXP fenpyroximate results in increased expression of EIF2S2 mRNA CTD PMID:33512557 NCBI chr20:34,088,309...34,112,243
Ensembl chr20:34,088,309...34,112,243
JBrowse link
G EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 increases expression EXP fenpyroximate results in increased expression of EIF4EBP1 mRNA CTD PMID:33512557 NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
JBrowse link
G ELMOD1 ELMO domain containing 1 decreases expression EXP fenpyroximate results in decreased expression of ELMOD1 mRNA CTD PMID:33512557 NCBI chr11:107,591,009...107,666,779
Ensembl chr11:107,591,091...107,666,779
JBrowse link
G EP300 E1A binding protein p300 decreases expression EXP fenpyroximate results in decreased expression of EP300 mRNA CTD PMID:33512557 NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,592...41,180,077
JBrowse link
G EPHB2 EPH receptor B2 decreases expression EXP fenpyroximate results in decreased expression of EPHB2 mRNA CTD PMID:33512557 NCBI chr 1:22,710,770...22,921,500
Ensembl chr 1:22,710,839...22,921,500
JBrowse link
G ERO1A endoplasmic reticulum oxidoreductase 1 alpha increases expression EXP fenpyroximate results in increased expression of ERO1A mRNA CTD PMID:33512557 NCBI chr14:52,639,915...52,695,750
Ensembl chr14:52,639,915...52,695,900
JBrowse link
G ERO1B endoplasmic reticulum oxidoreductase 1 beta increases expression EXP fenpyroximate results in increased expression of ERO1B mRNA CTD PMID:33512557 NCBI chr 1:236,213,064...236,281,983
Ensembl chr 1:236,215,101...236,281,958
JBrowse link
G ESR2 estrogen receptor 2 multiple interactions EXP fenpyroximate inhibits the reaction [Estradiol results in increased activity of ESR2 protein] CTD PMID:30818834 NCBI chr14:64,226,707...64,338,631
Ensembl chr14:64,084,232...64,338,112
JBrowse link
G ESRRA estrogen related receptor alpha multiple interactions EXP fenpyroximate inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein]; fenpyroximate inhibits the reaction [XCT790 results in decreased activity of ESRRA protein] CTD PMID:30818834 NCBI chr11:64,305,524...64,316,743
Ensembl chr11:64,305,497...64,316,743
JBrowse link
G EXOSC4 exosome component 4 decreases expression EXP fenpyroximate results in decreased expression of EXOSC4 mRNA CTD PMID:33512557 NCBI chr 8:144,064,061...144,080,648
Ensembl chr 8:144,078,648...144,080,648
JBrowse link
G EXOSC8 exosome component 8 increases expression EXP fenpyroximate results in increased expression of EXOSC8 mRNA CTD PMID:33512557 NCBI chr13:37,000,373...37,009,614
Ensembl chr13:36,998,816...37,009,614
JBrowse link
G FAM72A family with sequence similarity 72 member A increases expression EXP fenpyroximate results in increased expression of FAM72A mRNA CTD PMID:33512557 NCBI chr 1:206,186,179...206,205,773
Ensembl chr 1:206,186,179...206,204,414
JBrowse link
G FAM72C family with sequence similarity 72 member C increases expression EXP fenpyroximate results in increased expression of FAM72C mRNA CTD PMID:33512557 NCBI chr 1:143,955,287...143,973,564
Ensembl chr 1:143,955,287...143,971,986
JBrowse link
G FBL fibrillarin increases expression EXP fenpyroximate results in increased expression of FBL mRNA CTD PMID:33512557 NCBI chr19:39,834,458...39,846,395
Ensembl chr19:39,834,458...39,846,379
JBrowse link
G FBXO7 F-box protein 7 decreases expression EXP fenpyroximate results in decreased expression of FBXO7 mRNA CTD PMID:33512557 NCBI chr22:32,474,682...32,498,829
Ensembl chr22:32,474,676...32,498,829
JBrowse link
G FGF2 fibroblast growth factor 2 increases expression EXP fenpyroximate results in increased expression of FGF2 mRNA CTD PMID:33512557 NCBI chr 4:122,826,708...122,898,236
Ensembl chr 4:122,826,708...122,898,236
JBrowse link
G FTH1 ferritin heavy chain 1 increases expression EXP fenpyroximate results in increased expression of FTH1 mRNA CTD PMID:33512557 NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
JBrowse link
G FTL ferritin light chain increases expression EXP fenpyroximate results in increased expression of FTL mRNA CTD PMID:33512557 NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
JBrowse link
G G6PC1 glucose-6-phosphatase catalytic subunit 1 decreases expression EXP fenpyroximate results in decreased expression of G6PC1 mRNA CTD PMID:32194361 NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
JBrowse link
G G6PD glucose-6-phosphate dehydrogenase decreases expression EXP fenpyroximate results in decreased expression of G6PD mRNA CTD PMID:33512557 NCBI chr  X:154,531,390...154,547,569
Ensembl chr  X:154,531,391...154,547,572
JBrowse link
G GADD45B growth arrest and DNA damage inducible beta increases expression EXP fenpyroximate results in increased expression of GADD45B mRNA CTD PMID:33512557 NCBI chr19:2,476,127...2,478,259
Ensembl chr19:2,476,122...2,478,259
JBrowse link
G GADD45G growth arrest and DNA damage inducible gamma increases expression EXP fenpyroximate results in increased expression of GADD45G mRNA CTD PMID:33512557 NCBI chr 9:89,605,009...89,606,555
Ensembl chr 9:89,605,012...89,606,555
JBrowse link
G GAP43 growth associated protein 43 decreases expression EXP fenpyroximate results in decreased expression of GAP43 mRNA CTD PMID:33512557 NCBI chr 3:115,623,510...115,721,485
Ensembl chr 3:115,623,510...115,721,490
JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit increases expression EXP fenpyroximate results in increased expression of GCLM mRNA CTD PMID:33512557 NCBI chr 1:93,885,199...93,910,370
Ensembl chr 1:93,885,199...93,909,456
JBrowse link
G GDF15 growth differentiation factor 15 increases expression EXP fenpyroximate results in increased expression of GDF15 mRNA CTD PMID:33512557 NCBI chr19:18,382,170...18,389,176
Ensembl chr19:18,374,731...18,389,176
JBrowse link
G GFUS GDP-L-fucose synthase increases expression EXP fenpyroximate results in increased expression of GFUS mRNA CTD PMID:33512557 NCBI chr 8:143,612,618...143,618,043
Ensembl chr 8:143,612,618...143,618,048
JBrowse link
G GLDC glycine decarboxylase decreases expression EXP fenpyroximate results in decreased expression of GLDC mRNA CTD PMID:33512557 NCBI chr 9:6,532,467...6,645,729
Ensembl chr 9:6,532,467...6,645,729
JBrowse link
G GLI3 GLI family zinc finger 3 decreases expression EXP fenpyroximate results in decreased expression of GLI3 mRNA CTD PMID:33512557 NCBI chr 7:41,960,949...42,237,209
Ensembl chr 7:41,960,949...42,264,100
JBrowse link
G GLRX glutaredoxin decreases expression EXP fenpyroximate results in decreased expression of GLRX mRNA CTD PMID:33512557 NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
JBrowse link
G GNAI2 G protein subunit alpha i2 decreases expression EXP fenpyroximate results in decreased expression of GNAI2 mRNA CTD PMID:33512557 NCBI chr 3:50,227,068...50,259,362
Ensembl chr 3:50,226,292...50,259,362
JBrowse link
G GRB10 growth factor receptor bound protein 10 increases expression EXP fenpyroximate results in increased expression of GRB10 mRNA CTD PMID:33512557 NCBI chr 7:50,590,068...50,793,453
Ensembl chr 7:50,590,063...50,793,462
JBrowse link
G GRM4 glutamate metabotropic receptor 4 decreases expression EXP fenpyroximate results in decreased expression of GRM4 mRNA CTD PMID:33512557 NCBI chr 6:34,018,643...34,155,622
Ensembl chr 6:34,018,643...34,155,622
JBrowse link
G GSTM2 glutathione S-transferase mu 2 decreases expression EXP fenpyroximate results in decreased expression of GSTM2 mRNA CTD PMID:33512557 NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
JBrowse link
G H1-2 H1.2 linker histone, cluster member increases expression EXP fenpyroximate results in increased expression of H1-2 mRNA CTD PMID:33512557 NCBI chr 6:26,055,740...26,056,470
Ensembl chr 6:26,055,740...26,056,470
JBrowse link
G H2AC11 H2A clustered histone 11 increases expression EXP fenpyroximate results in increased expression of H2AC11 mRNA CTD PMID:33512557 NCBI chr 6:27,133,043...27,133,535
Ensembl chr 6:27,133,042...27,135,291
JBrowse link
G H2AC15 H2A clustered histone 15 increases expression EXP fenpyroximate results in increased expression of H2AC15 mRNA CTD PMID:33512557 NCBI chr 6:27,837,880...27,838,375
Ensembl chr 6:27,837,880...27,838,375
JBrowse link
G H2AC19 H2A clustered histone 19 increases expression EXP fenpyroximate results in increased expression of H2AC19 mRNA CTD PMID:33512557 NCBI chr 1:149,851,061...149,851,594
Ensembl chr 1:149,851,061...149,851,624
JBrowse link
G H2AC6 H2A clustered histone 6 increases expression EXP fenpyroximate results in increased expression of H2AC6 mRNA CTD PMID:33512557 NCBI chr 6:26,124,172...26,124,690
Ensembl chr 6:26,124,145...26,139,116
JBrowse link
G H2AC8 H2A clustered histone 8 increases expression EXP fenpyroximate results in increased expression of H2AC8 mRNA CTD PMID:33512557 NCBI chr 6:26,216,921...26,217,483
Ensembl chr 6:26,216,975...26,217,483
JBrowse link
G H2BC13 H2B clustered histone 13 increases expression EXP fenpyroximate results in increased expression of H2BC13 mRNA CTD PMID:33512557 NCBI chr 6:27,807,479...27,807,929
Ensembl chr 6:27,807,444...27,807,931
JBrowse link
G H2BC14 H2B clustered histone 14 increases expression EXP fenpyroximate results in increased expression of H2BC14 mRNA CTD PMID:33512557 NCBI chr 6:27,815,022...27,815,489
Ensembl chr 6:27,815,022...27,815,489
JBrowse link
G H2BC15 H2B clustered histone 15 increases expression EXP fenpyroximate results in increased expression of H2BC15 mRNA CTD PMID:33512557 NCBI chr 6:27,838,569...27,839,110
Ensembl chr 6:27,837,760...27,855,709
JBrowse link
G H2BC3 H2B clustered histone 3 increases expression EXP fenpyroximate results in increased expression of H2BC3 mRNA CTD PMID:33512557 NCBI chr 6:26,043,227...26,043,713
Ensembl chr 6:26,043,227...26,043,713
JBrowse link
G H2BC5 H2B clustered histone 5 increases expression EXP fenpyroximate results in increased expression of H2BC5 mRNA CTD PMID:33512557 NCBI chr 6:26,158,008...26,171,349
Ensembl chr 6:26,158,146...26,171,349
JBrowse link
G H2BC9 H2B clustered histone 9 increases expression EXP fenpyroximate results in increased expression of H2BC9 mRNA CTD PMID:33512557 NCBI chr 6:26,251,614...26,252,075
Ensembl chr 6:26,251,651...26,253,710
JBrowse link
G H3C10 H3 clustered histone 10 increases expression EXP fenpyroximate results in increased expression of H3C10 mRNA CTD PMID:33512557 NCBI chr 6:27,810,051...27,810,536
Ensembl chr 6:27,810,064...27,811,300
JBrowse link
G H3C2 H3 clustered histone 2 increases expression EXP fenpyroximate results in increased expression of H3C2 mRNA CTD PMID:33512557 NCBI chr 6:26,031,589...26,032,099
Ensembl chr 6:26,031,589...26,032,099
JBrowse link
G H3C3 H3 clustered histone 3 increases expression EXP fenpyroximate results in increased expression of H3C3 mRNA CTD PMID:33512557 NCBI chr 6:26,045,384...26,045,869
Ensembl chr 6:26,045,384...26,045,869
JBrowse link
G H3C4 H3 clustered histone 4 increases expression EXP fenpyroximate results in increased expression of H3C4 mRNA CTD PMID:33512557 NCBI chr 6:26,196,784...26,199,293
Ensembl chr 6:26,196,784...26,197,286
JBrowse link
G HCST hematopoietic cell signal transducer increases expression EXP fenpyroximate results in increased expression of HCST mRNA CTD PMID:33512557 NCBI chr19:35,902,365...35,904,377
Ensembl chr19:35,902,529...35,904,377
JBrowse link
G HDAC2 histone deacetylase 2 decreases expression EXP fenpyroximate results in decreased expression of HDAC2 mRNA CTD PMID:33512557 NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
JBrowse link
G HERPUD1 homocysteine inducible ER protein with ubiquitin like domain 1 increases expression EXP fenpyroximate results in increased expression of HERPUD1 mRNA CTD PMID:33512557 NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
JBrowse link
G HES1 hes family bHLH transcription factor 1 increases expression EXP fenpyroximate results in increased expression of HES1 mRNA CTD PMID:33512557 NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
JBrowse link
G HMOX1 heme oxygenase 1 increases expression EXP fenpyroximate results in increased expression of HMOX1 mRNA CTD PMID:33512557 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G HNRNPM heterogeneous nuclear ribonucleoprotein M decreases expression EXP fenpyroximate results in decreased expression of HNRNPM mRNA CTD PMID:33512557 NCBI chr19:8,444,575...8,489,114
Ensembl chr19:8,444,767...8,489,114
JBrowse link
G HSP90B1 heat shock protein 90 beta family member 1 increases expression EXP fenpyroximate results in increased expression of HSP90B1 mRNA CTD PMID:33512557 NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
JBrowse link
G HSPA1B heat shock protein family A (Hsp70) member 1B increases expression EXP fenpyroximate results in increased expression of HSPA1B mRNA CTD PMID:33512557 NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
JBrowse link
G HSPE1 heat shock protein family E (Hsp10) member 1 increases expression EXP fenpyroximate results in increased expression of HSPE1 mRNA CTD PMID:33512557 NCBI chr 2:197,500,379...197,503,449
Ensembl chr 2:197,500,140...197,503,449
JBrowse link
G HTATSF1 HIV-1 Tat specific factor 1 decreases expression EXP fenpyroximate results in decreased expression of HTATSF1 mRNA CTD PMID:33512557 NCBI chr  X:136,497,227...136,512,346
Ensembl chr  X:136,497,079...136,512,346
JBrowse link
G ID1 inhibitor of DNA binding 1, HLH protein decreases expression EXP fenpyroximate results in decreased expression of ID1 mRNA CTD PMID:33512557 NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
JBrowse link
G ID2 inhibitor of DNA binding 2 increases expression EXP fenpyroximate results in increased expression of ID2 mRNA CTD PMID:33512557 NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
JBrowse link
G IFRD1 interferon related developmental regulator 1 increases expression EXP fenpyroximate results in increased expression of IFRD1 mRNA CTD PMID:33512557 NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017
JBrowse link
G IGF1R insulin like growth factor 1 receptor decreases expression EXP fenpyroximate results in decreased expression of IGF1R mRNA CTD PMID:33512557 NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
JBrowse link
G IGFBP2 insulin like growth factor binding protein 2 decreases expression EXP fenpyroximate results in decreased expression of IGFBP2 mRNA CTD PMID:33512557 NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436
JBrowse link
G INA internexin neuronal intermediate filament protein alpha decreases expression EXP fenpyroximate results in decreased expression of INA mRNA CTD PMID:33512557 NCBI chr10:103,277,138...103,290,346
Ensembl chr10:103,277,138...103,290,346
JBrowse link
G IPO5 importin 5 increases expression EXP fenpyroximate results in increased expression of IPO5 mRNA CTD PMID:33512557 NCBI chr13:97,953,641...98,024,296
Ensembl chr13:97,953,658...98,024,296
JBrowse link
G ITPR2 inositol 1,4,5-trisphosphate receptor type 2 decreases expression EXP fenpyroximate results in decreased expression of ITPR2 mRNA CTD PMID:33512557 NCBI chr12:26,335,352...26,833,197
Ensembl chr12:26,335,352...26,833,194
JBrowse link
G JMJD6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase increases expression EXP fenpyroximate results in increased expression of JMJD6 mRNA CTD PMID:33512557 NCBI chr17:76,712,830...76,726,783
Ensembl chr17:76,712,832...76,726,799
JBrowse link
G KDM3A lysine demethylase 3A decreases expression EXP fenpyroximate results in decreased expression of KDM3A mRNA CTD PMID:33512557 NCBI chr 2:86,440,647...86,492,716
Ensembl chr 2:86,440,647...86,492,716
JBrowse link
G KDM5B lysine demethylase 5B decreases expression EXP fenpyroximate results in decreased expression of KDM5B mRNA CTD PMID:33512557 NCBI chr 1:202,724,495...202,809,470
Ensembl chr 1:202,724,495...202,808,487
JBrowse link
G KIF15 kinesin family member 15 increases expression EXP fenpyroximate results in increased expression of KIF15 mRNA CTD PMID:33512557 NCBI chr 3:44,761,740...44,853,274
Ensembl chr 3:44,761,721...44,873,376
JBrowse link
G KIF20A kinesin family member 20A increases expression EXP fenpyroximate results in increased expression of KIF20A mRNA CTD PMID:33512557 NCBI chr 5:138,179,112...138,187,723
Ensembl chr 5:138,178,719...138,187,723
JBrowse link
G KIF5C kinesin family member 5C decreases expression EXP fenpyroximate results in decreased expression of KIF5C mRNA CTD PMID:33512557 NCBI chr 2:148,875,227...149,026,759
Ensembl chr 2:148,875,227...149,026,759
JBrowse link
G KNL1 kinetochore scaffold 1 increases expression EXP fenpyroximate results in increased expression of KNL1 mRNA CTD PMID:33512557 NCBI chr15:40,594,012...40,664,342
Ensembl chr15:40,594,020...40,664,342
JBrowse link
G KYAT3 kynurenine aminotransferase 3 decreases expression EXP fenpyroximate results in decreased expression of KYAT3 mRNA CTD PMID:33512557 NCBI chr 1:88,921,044...88,992,960
Ensembl chr 1:88,935,773...88,992,953
JBrowse link
G LOXL1 lysyl oxidase like 1 decreases expression EXP fenpyroximate results in decreased expression of LOXL1 mRNA CTD PMID:33512557 NCBI chr15:73,926,462...73,952,137
Ensembl chr15:73,925,989...73,952,137
JBrowse link
G LRRC41 leucine rich repeat containing 41 decreases expression EXP fenpyroximate results in decreased expression of LRRC41 mRNA CTD PMID:33512557 NCBI chr 1:46,277,462...46,303,616
Ensembl chr 1:46,261,196...46,303,616
JBrowse link
G MANF mesencephalic astrocyte derived neurotrophic factor increases expression EXP fenpyroximate results in increased expression of MANF mRNA CTD PMID:33512557 NCBI chr 3:51,385,291...51,389,397
Ensembl chr 3:51,385,291...51,389,397
JBrowse link
G MAP1B microtubule associated protein 1B decreases expression EXP fenpyroximate results in decreased expression of MAP1B mRNA CTD PMID:33512557 NCBI chr 5:72,107,475...72,209,565
Ensembl chr 5:72,107,234...72,209,565
JBrowse link
G MAP6 microtubule associated protein 6 decreases expression EXP fenpyroximate results in decreased expression of MAP6 mRNA CTD PMID:33512557 NCBI chr11:75,586,914...75,669,038
Ensembl chr11:75,586,918...75,669,038
JBrowse link
G MCM7 minichromosome maintenance complex component 7 increases expression EXP fenpyroximate results in increased expression of MCM7 mRNA CTD PMID:33512557 NCBI chr 7:100,092,728...100,101,397
Ensembl chr 7:100,092,728...100,101,940
JBrowse link
G MDK midkine increases expression EXP fenpyroximate results in increased expression of MDK mRNA CTD PMID:33512557 NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
JBrowse link
G ME1 malic enzyme 1 increases expression EXP fenpyroximate results in increased expression of ME1 mRNA CTD PMID:33512557 NCBI chr 6:83,210,402...83,431,078
Ensembl chr 6:83,210,402...83,431,051
JBrowse link
G MKI67 marker of proliferation Ki-67 increases expression EXP fenpyroximate results in increased expression of MKI67 mRNA CTD PMID:33512557 NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
JBrowse link
G MLLT11 MLLT11 transcription factor 7 cofactor decreases expression EXP fenpyroximate results in decreased expression of MLLT11 mRNA CTD PMID:33512557 NCBI chr 1:151,060,397...151,069,544
Ensembl chr 1:151,060,397...151,069,544
JBrowse link
G MNAT1 MNAT1 component of CDK activating kinase decreases expression EXP fenpyroximate results in decreased expression of MNAT1 mRNA CTD PMID:33512557 NCBI chr14:60,734,735...60,969,965
Ensembl chr14:60,734,742...60,969,965
JBrowse link
G MORN2 MORN repeat containing 2 decreases expression EXP fenpyroximate results in decreased expression of MORN2 mRNA CTD PMID:33512557 NCBI chr 2:38,875,976...38,882,709
Ensembl chr 2:38,875,962...38,929,072
JBrowse link
G MSI2 musashi RNA binding protein 2 decreases expression EXP fenpyroximate results in decreased expression of MSI2 mRNA CTD PMID:33512557 NCBI chr17:57,255,851...57,684,689
Ensembl chr17:57,255,851...57,684,689
JBrowse link
G MTA1 metastasis associated 1 decreases expression EXP fenpyroximate results in decreased expression of MTA1 mRNA CTD PMID:33512557 NCBI chr14:105,419,827...105,470,729
Ensembl chr14:105,419,820...105,470,729
JBrowse link
G MTHFD2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase increases expression EXP fenpyroximate results in increased expression of MTHFD2 mRNA CTD PMID:33512557 NCBI chr 2:74,198,591...74,217,565
Ensembl chr 2:74,186,172...74,217,565
JBrowse link
G NAV1 neuron navigator 1 decreases expression EXP fenpyroximate results in decreased expression of NAV1 mRNA CTD PMID:33512557 NCBI chr 1:201,539,127...201,826,969
Ensembl chr 1:201,622,885...201,826,969
JBrowse link
G NCAN neurocan decreases expression EXP fenpyroximate results in decreased expression of NCAN mRNA CTD PMID:33512557 NCBI chr19:19,211,958...19,252,233
Ensembl chr19:19,211,958...19,252,233
JBrowse link
G NDUFA1 NADH:ubiquinone oxidoreductase subunit A1 increases expression EXP fenpyroximate results in increased expression of NDUFA1 mRNA CTD PMID:33512557 NCBI chr  X:119,871,832...119,876,662
Ensembl chr  X:119,871,832...119,876,662
JBrowse link
G NEK2 NIMA related kinase 2 increases expression EXP fenpyroximate results in increased expression of NEK2 mRNA CTD PMID:33512557 NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630
JBrowse link
G NFATC3 nuclear factor of activated T cells 3 decreases expression EXP fenpyroximate results in decreased expression of NFATC3 mRNA CTD PMID:33512557 NCBI chr16:68,085,370...68,229,259
Ensembl chr16:68,084,751...68,229,259
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 increases activity EXP fenpyroximate results in increased activity of NFE2L2 protein CTD PMID:30818834 NCBI chr 2:177,230,303...177,265,131
Ensembl chr 2:177,227,595...177,392,697
JBrowse link
G NFIL3 nuclear factor, interleukin 3 regulated decreases expression EXP fenpyroximate results in decreased expression of NFIL3 mRNA CTD PMID:33512557 NCBI chr 9:91,409,045...91,425,063
Ensembl chr 9:91,409,045...91,423,832
JBrowse link
G NFKBIB NFKB inhibitor beta decreases expression EXP fenpyroximate results in decreased expression of NFKBIB mRNA CTD PMID:33512557 NCBI chr19:38,899,503...38,908,894
Ensembl chr19:38,899,700...38,908,893
JBrowse link
G NIT1 nitrilase 1 decreases expression EXP fenpyroximate results in decreased expression of NIT1 mRNA CTD PMID:33512557 NCBI chr 1:161,118,092...161,125,446
Ensembl chr 1:161,118,086...161,125,445
JBrowse link
G NMNAT3 nicotinamide nucleotide adenylyltransferase 3 decreases response to substance ISO NMNAT3 protein results in decreased susceptibility to fenpyroximate CTD PMID:18463239 NCBI chr 3:139,560,180...139,678,050
Ensembl chr 3:139,560,180...139,678,017
JBrowse link
G NOTCH3 notch receptor 3 decreases expression EXP fenpyroximate results in decreased expression of NOTCH3 mRNA CTD PMID:33512557 NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 increases expression EXP fenpyroximate results in increased expression of NQO1 mRNA CTD PMID:33512557 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
JBrowse link
G NR2F1 nuclear receptor subfamily 2 group F member 1 decreases expression EXP fenpyroximate results in decreased expression of NR2F1 mRNA CTD PMID:33512557 NCBI chr 5:93,583,222...93,594,613
Ensembl chr 5:93,583,222...93,594,611
JBrowse link
G NR3C1 nuclear receptor subfamily 3 group C member 1 increases expression EXP fenpyroximate results in increased expression of NR3C1 mRNA CTD PMID:33512557 NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
JBrowse link
G NR5A1 nuclear receptor subfamily 5 group A member 1 decreases expression EXP fenpyroximate results in decreased expression of NR5A1 mRNA CTD PMID:33512557 NCBI chr 9:124,481,236...124,507,399
Ensembl chr 9:124,481,236...124,507,420
JBrowse link
G NRCAM neuronal cell adhesion molecule decreases expression EXP fenpyroximate results in decreased expression of NRCAM mRNA CTD PMID:33512557 NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
JBrowse link
G NRXN1 neurexin 1 decreases expression EXP fenpyroximate results in decreased expression of NRXN1 mRNA CTD PMID:33512557 NCBI chr 2:49,918,503...51,032,132
Ensembl chr 2:49,918,503...51,225,575
JBrowse link
G NTRK1 neurotrophic receptor tyrosine kinase 1 decreases expression EXP fenpyroximate results in decreased expression of NTRK1 mRNA CTD PMID:33512557 NCBI chr 1:156,815,750...156,881,850
Ensembl chr 1:156,815,640...156,881,850
JBrowse link
G OAZ1 ornithine decarboxylase antizyme 1 increases expression EXP fenpyroximate results in increased expression of OAZ1 mRNA CTD PMID:33512557 NCBI chr19:2,269,486...2,273,488
Ensembl chr19:2,269,509...2,273,490
JBrowse link
G OLFML2B olfactomedin like 2B decreases expression EXP fenpyroximate results in decreased expression of OLFML2B mRNA CTD PMID:33512557 NCBI chr 1:161,983,192...162,023,869
Ensembl chr 1:161,983,192...162,023,869
JBrowse link
G OSTC oligosaccharyltransferase complex non-catalytic subunit increases expression EXP fenpyroximate results in increased expression of OSTC mRNA CTD PMID:33512557 NCBI chr 4:108,650,599...108,667,820
Ensembl chr 4:108,650,585...108,667,820
JBrowse link
G PAFAH1B3 platelet activating factor acetylhydrolase 1b catalytic subunit 3 decreases expression EXP fenpyroximate results in decreased expression of PAFAH1B3 mRNA CTD PMID:33512557 NCBI chr19:42,297,033...42,302,800
Ensembl chr19:42,297,033...42,303,546
JBrowse link
G PARK7 Parkinsonism associated deglycase decreases response to substance ISO PARK7 protein results in decreased susceptibility to fenpyroximate CTD PMID:21219333 NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505
JBrowse link
G PARP2 poly(ADP-ribose) polymerase 2 increases expression EXP fenpyroximate results in increased expression of PARP2 mRNA CTD PMID:33512557 NCBI chr14:20,343,041...20,357,904
Ensembl chr14:20,343,615...20,357,904
JBrowse link
G PDIA6 protein disulfide isomerase family A member 6 increases expression EXP fenpyroximate results in increased expression of PDIA6 mRNA CTD PMID:33512557 NCBI chr 2:10,783,391...10,837,712
Ensembl chr 2:10,783,391...10,837,977
JBrowse link
G PEBP1 phosphatidylethanolamine binding protein 1 decreases expression EXP fenpyroximate results in decreased expression of PEBP1 mRNA CTD PMID:33512557 NCBI chr12:118,136,124...118,145,584
Ensembl chr12:118,136,124...118,145,584
JBrowse link
G PEG10 paternally expressed 10 decreases expression EXP fenpyroximate results in decreased expression of PEG10 mRNA CTD PMID:33512557 NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
JBrowse link
G PGM3 phosphoglucomutase 3 increases expression EXP fenpyroximate results in increased expression of PGM3 mRNA CTD PMID:33512557 NCBI chr 6:83,150,728...83,193,900
Ensembl chr 6:83,161,150...83,193,936
JBrowse link
G PGR progesterone receptor multiple interactions EXP fenpyroximate inhibits the reaction [Promegestone results in increased activity of PGR protein] CTD PMID:30818834 NCBI chr11:101,029,624...101,130,681
Ensembl chr11:101,029,624...101,129,813
JBrowse link
G PHGDH phosphoglycerate dehydrogenase increases expression EXP fenpyroximate results in increased expression of PHGDH mRNA CTD PMID:33512557 NCBI chr 1:119,711,934...119,744,218
Ensembl chr 1:119,648,411...119,744,218
JBrowse link
G PHLDA1 pleckstrin homology like domain family A member 1 decreases expression EXP fenpyroximate results in decreased expression of PHLDA1 mRNA CTD PMID:33512557 NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776
JBrowse link
G PIK3C2B phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta decreases expression EXP fenpyroximate results in decreased expression of PIK3C2B mRNA CTD PMID:33512557 NCBI chr 1:204,422,633...204,494,815
Ensembl chr 1:204,422,628...204,494,805
JBrowse link
G PINK1 PTEN induced kinase 1 decreases expression EXP fenpyroximate results in decreased expression of PINK1 mRNA CTD PMID:33512557 NCBI chr 1:20,633,458...20,651,511
Ensembl chr 1:20,633,458...20,651,511
JBrowse link
G PIP4K2B phosphatidylinositol-5-phosphate 4-kinase type 2 beta decreases expression EXP fenpyroximate results in decreased expression of PIP4K2B mRNA CTD PMID:33512557 NCBI chr17:38,765,691...38,799,576
Ensembl chr17:38,765,691...38,800,126
JBrowse link
G PITPNA phosphatidylinositol transfer protein alpha decreases expression EXP fenpyroximate results in decreased expression of PITPNA mRNA CTD PMID:33512557 NCBI chr17:1,517,718...1,562,803
Ensembl chr17:1,517,718...1,562,792
JBrowse link
G PLIN2 perilipin 2 increases expression EXP fenpyroximate results in increased expression of PLIN2 mRNA CTD PMID:33512557 NCBI chr 9:19,108,391...19,127,518
Ensembl chr 9:19,108,375...19,149,290
JBrowse link
G POLE3 DNA polymerase epsilon 3, accessory subunit increases expression EXP fenpyroximate results in increased expression of POLE3 mRNA CTD PMID:33512557 NCBI chr 9:113,407,235...113,410,749
Ensembl chr 9:113,407,235...113,410,675
JBrowse link
G PPARGC1A PPARG coactivator 1 alpha multiple interactions EXP fenpyroximate inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein] CTD PMID:30818834 NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
JBrowse link
G PPP2R1A protein phosphatase 2 scaffold subunit Aalpha decreases expression EXP fenpyroximate results in decreased expression of PPP2R1A mRNA CTD PMID:33512557 NCBI chr19:52,190,052...52,229,518
Ensembl chr19:52,190,048...52,229,518
JBrowse link
G PRKAG1 protein kinase AMP-activated non-catalytic subunit gamma 1 decreases expression EXP fenpyroximate results in decreased expression of PRKAG1 mRNA CTD PMID:33512557 NCBI chr12:49,002,272...49,018,975
Ensembl chr12:49,002,274...49,018,807
JBrowse link
G PRKAR1A protein kinase cAMP-dependent type I regulatory subunit alpha decreases expression EXP fenpyroximate results in decreased expression of PRKAR1A mRNA CTD PMID:33512557 NCBI chr17:68,413,623...68,551,316
Ensembl chr17:68,511,780...68,551,319
JBrowse link
G PRKN parkin RBR E3 ubiquitin protein ligase decreases expression EXP fenpyroximate results in decreased expression of PRKN mRNA CTD PMID:33512557 NCBI chr 6:161,347,417...162,727,802
Ensembl chr 6:161,347,417...162,727,775
JBrowse link
G PRR11 proline rich 11 increases expression EXP fenpyroximate results in increased expression of PRR11 mRNA CTD PMID:33512557 NCBI chr17:59,155,355...59,206,709
Ensembl chr17:59,155,732...59,206,709
JBrowse link
G PSAT1 phosphoserine aminotransferase 1 increases expression EXP fenpyroximate results in increased expression of PSAT1 mRNA CTD PMID:33512557 NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093
JBrowse link
G PSMA1 proteasome 20S subunit alpha 1 increases expression EXP fenpyroximate results in increased expression of PSMA1 mRNA CTD PMID:33512557 NCBI chr11:14,504,876...14,643,662
Ensembl chr11:14,504,874...14,643,635
JBrowse link
G PTK2B protein tyrosine kinase 2 beta decreases expression EXP fenpyroximate results in decreased expression of PTK2B mRNA CTD PMID:33512557 NCBI chr 8:27,311,478...27,459,391
Ensembl chr 8:27,311,482...27,459,391
JBrowse link
G RIPK1 receptor interacting serine/threonine kinase 1 decreases expression EXP fenpyroximate results in decreased expression of RIPK1 mRNA CTD PMID:33512557 NCBI chr 6:3,063,967...3,115,187
Ensembl chr 6:3,063,824...3,115,187
JBrowse link
G RNF4 ring finger protein 4 increases expression EXP fenpyroximate results in increased expression of RNF4 mRNA CTD PMID:33512557 NCBI chr 4:2,469,106...2,515,857
Ensembl chr 4:2,462,220...2,625,320
JBrowse link
G RNPS1 RNA binding protein with serine rich domain 1 decreases expression EXP fenpyroximate results in decreased expression of RNPS1 mRNA CTD PMID:33512557 NCBI chr16:2,253,116...2,268,126
Ensembl chr16:2,253,116...2,268,397
JBrowse link
G RPA3 replication protein A3 increases expression EXP fenpyroximate results in increased expression of RPA3 mRNA CTD PMID:33512557 NCBI chr 7:7,636,518...7,718,607
Ensembl chr 7:7,636,518...7,718,607
JBrowse link
G RPL11 ribosomal protein L11 increases expression EXP fenpyroximate results in increased expression of RPL11 mRNA CTD PMID:33512557 NCBI chr 1:23,691,779...23,696,835
Ensembl chr 1:23,691,742...23,696,835
JBrowse link
G RPL17 ribosomal protein L17 increases expression EXP fenpyroximate results in increased expression of RPL17 mRNA CTD PMID:33512557 NCBI chr18:49,488,481...49,492,465
Ensembl chr18:49,488,453...49,492,508
JBrowse link
G RPL27 ribosomal protein L27 increases expression EXP fenpyroximate results in increased expression of RPL27 mRNA CTD PMID:33512557 NCBI chr17:42,998,273...43,002,959
Ensembl chr17:42,998,273...43,002,959
JBrowse link
G RPL28 ribosomal protein L28 increases expression EXP fenpyroximate results in increased expression of RPL28 mRNA CTD PMID:33512557 NCBI chr19:55,385,932...55,403,342
Ensembl chr19:55,385,932...55,403,250
JBrowse link
G RPL32 ribosomal protein L32 increases expression EXP fenpyroximate results in increased expression of RPL32 mRNA CTD PMID:33512557 NCBI chr 3:12,834,485...12,841,582
Ensembl chr 3:12,834,485...12,841,582
JBrowse link
G RPL36 ribosomal protein L36 increases expression EXP fenpyroximate results in increased expression of RPL36 mRNA CTD PMID:33512557 NCBI chr19:5,690,295...5,691,875
Ensembl chr19:5,674,947...5,691,875
JBrowse link
G RPL36AL ribosomal protein L36a like increases expression EXP fenpyroximate results in increased expression of RPL36AL mRNA CTD PMID:33512557 NCBI chr14:49,618,530...49,620,626
Ensembl chr14:49,618,530...49,620,626
JBrowse link
G RPL9 ribosomal protein L9 increases expression EXP fenpyroximate results in increased expression of RPL9 mRNA CTD PMID:33512557 NCBI chr 4:39,454,124...39,458,922
Ensembl chr 4:39,452,587...39,458,931
JBrowse link
G RPS13 ribosomal protein S13 increases expression EXP fenpyroximate results in increased expression of RPS13 mRNA CTD PMID:33512557 NCBI chr11:17,074,388...17,077,667
Ensembl chr11:17,074,388...17,077,715
JBrowse link
G RPS18 ribosomal protein S18 increases expression EXP fenpyroximate results in increased expression of RPS18 mRNA CTD PMID:33512557 NCBI chr 6:33,272,075...33,276,511
Ensembl chr 6:33,272,075...33,276,511
JBrowse link
G RPS2 ribosomal protein S2 increases expression EXP fenpyroximate results in increased expression of RPS2 mRNA CTD PMID:33512557 NCBI chr16:1,962,058...1,964,826
Ensembl chr16:1,962,058...1,964,841
JBrowse link
G RPS25 ribosomal protein S25 increases expression EXP fenpyroximate results in increased expression of RPS25 mRNA CTD PMID:33512557 NCBI chr11:119,015,717...119,018,343
Ensembl chr11:119,015,712...119,018,691
JBrowse link
G RPS27A ribosomal protein S27a increases expression EXP fenpyroximate results in increased expression of RPS27A mRNA CTD PMID:33512557 NCBI chr 2:55,231,903...55,235,853
Ensembl chr 2:55,231,903...55,235,853
JBrowse link
G RPS3 ribosomal protein S3 increases expression EXP fenpyroximate results in increased expression of RPS3 mRNA CTD PMID:33512557 NCBI chr11:75,399,518...75,422,302
Ensembl chr11:75,399,515...75,422,280
JBrowse link
G RPS5 ribosomal protein S5 increases expression EXP fenpyroximate results in increased expression of RPS5 mRNA CTD PMID:33512557 NCBI chr19:58,387,269...58,394,804
Ensembl chr19:58,386,400...58,394,806
JBrowse link
G RPS7 ribosomal protein S7 increases expression EXP fenpyroximate results in increased expression of RPS7 mRNA CTD PMID:33512557 NCBI chr 2:3,575,260...3,580,920
Ensembl chr 2:3,575,260...3,580,920
JBrowse link
G RSL24D1 ribosomal L24 domain containing 1 increases expression EXP fenpyroximate results in increased expression of RSL24D1 mRNA CTD PMID:33512557 NCBI chr15:55,180,806...55,196,941
Ensembl chr15:55,180,806...55,197,049
JBrowse link
G S100A13 S100 calcium binding protein A13 increases expression EXP fenpyroximate results in increased expression of S100A13 mRNA CTD PMID:33512557 NCBI chr 1:153,618,799...153,634,361
Ensembl chr 1:153,618,787...153,631,360
JBrowse link
G S100A4 S100 calcium binding protein A4 increases expression EXP fenpyroximate results in increased expression of S100A4 mRNA CTD PMID:33512557 NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136
JBrowse link
G S100P S100 calcium binding protein P increases expression EXP fenpyroximate results in increased expression of S100P mRNA; fenpyroximate results in increased expression of S100P protein CTD PMID:32194361 NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170
JBrowse link
G SATB1 SATB homeobox 1 decreases expression EXP fenpyroximate results in decreased expression of SATB1 mRNA CTD PMID:33512557 NCBI chr 3:18,345,377...18,445,592
Ensembl chr 3:18,345,377...18,445,588
JBrowse link
G SELENOS selenoprotein S increases expression EXP fenpyroximate results in increased expression of SELENOS mRNA CTD PMID:33512557 NCBI chr15:101,270,809...101,277,485
Ensembl chr15:101,270,817...101,277,500
JBrowse link
G SEMA4B